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Abstract 
A 24-hour static batch in vitro fermentation model using human fecal microflora was 
used to evaluate the prebiotic effect of sugar alcohols including xylitol, sorbitol, 
mannitol and lactitol with fructo-oligosaccharides (FOS) as the positive control. All 
sugar alcohols had a dry matter disappearance (DMD) and organic matter 
disappearance (OMD) values larger than 87% except xylitol that had both values 
below 60%. Generally, a significant increase (p<0.05) in the production of 
short-chain fatty acids (SCFAs) and a significant reduction in the colonic pH (p<0.05) 
were found in all sugar alcohols. Genus-specific 16S rRNA-targeted oligonucleotide 
probes used in fluorescent in situ hybridisation (FISH) were validated by using pure 
bacterial culture of the human intestine. As shown by FISH, all sugar alcohols did 
not show a stimulatory effect upon Lactobacilli population while they all reduced 
Clostridia counts. While only lactitol significantly increased (p><0.05) the total 
bacterial and bifidobacteria! population, xylitol was the only sugar alcohol that 
inhibited the growth of Bacteroides, Bifidobacteria and Clostridia populations. 
Lactitol was the most potent sugar alcohol prebiotics due to its selective increase in 
the Bifidobacteria population and reduction of Clostridia counts in the above study 
and was chosen to be further investigated together with FOS in the subsequent 
three-stage continuous in vitro fermentation system. 
A modified three-stage continuous in vitro fermentation system, consisted of three 
glass vessels (vessel 1 to 3) aligned in series which simulated the environmental 
conditions found in the human proximal, transverse and distal colon, respectively, 
was developed in this study. The fermentation activity of FOS and lactitol was 
predominant in vessel 1, because of the adequate nutrients supply. Both lactitol and 
iv 
FOS were found to increase the butyrate ratio in the total short-chain fatty acids with 
butyrate as the second major short-chain fatty acid after acetate. However, the 
significant increase (p<0.05) in Bifidobacteria and short-chain fatty acid production 
as well as significant reduction (^<0.05) in Clostridia by lactitol and FOS in vessel 1 
could not be sustained in both vessels 2 and 3. 
Lactitol was found to be the most potent prebiotics among all the sugar alcohols 
tested. Further investigations on the in vivo and human clinical studies are required to 
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Chapter 1. Introduction 
1.1 What are prebiotics? 
Prebiotics are defined as 'non-digestible food ingredients that beneficially affect the 
host by selectively stimulating the growth and/or activity of one or a limited number 
of colonic bacteria, and thus improve the host health' (Gibson and Roberfroid, 1995). 
To determine whether a food substrate can act as a prebiotic agent, it has to satisfy 
with three criteria. First, it has to resist the acidic gastric environment, mammalian 
enzymatic hydrolysis and gastrointestinal absorption. Second, it is fermented by the 
intestinal microflora. Fermentation is an anaerobic redox reaction, in which 
adenosine triphosphate (ATP) is generated via substrate-level phosphorylation 
coupled to the partial oxidation of the substrate, leaving the key metabolic 
intermediates such as pyruvate (Chaia and Oliver, 2003). The most important 
criterion is that, a prebiotic agent should not stimulate the entire colonic microflora 
population, but selectively ’ stimulate the growth and/ or activity of the intestinal 
bacteria associated with human health and well-being (Niness, 1999). Among the 
human colonic microbes, Bifidobacteria and Lactobacilli are the usual target genera 
for prebiotics and are regarded as health-promoting bacteria since their population 
size in the community is associated with the health of the host (Gibson and 
Roberfroid, 1995). 
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1.2 Current prebiotics and their development 
Up till now, only fructo-oligosaccharides (also known as oligofructose), inulin, 
transgalacto-oligosaccharides (also known as galacto-oligosaccharides) and lactulose 
have significant in vitro, in vivo as well as human clinical evidence to support them 
being classified as prebiotics (Gibson et al, 2004). Linear chain of inulin and 
fructo-oligosaccharides are either an a-D-glucopyranosyl-(l ->2) 
[-P-D-fructofuranosyl-( 1 ->2)]n-P-D-fructofuranoside (GpyFn) or a 
P-D-fructopyranosyl-(l — 2) [P-D-fructofuranosyl-( 1 ^ 2)]n-P-D-fructofliranoside (Fn), 
in which inulin with the degree of polymerisation from ten to sixty while 
fructo-oligosaccharides with the maximum degree of polymerisation less than ten 
(figure 1.1). While inulin and fructo-oligosaccharides are commonly found in various 
edible plants such as onion, leek, Jerusalem artichoke and chicory, they also can be 
synthesized by transfructosylation with P-fructosidase (Franck, 2002). 
( G p y F n ) F „ 
OM O M 
0 
i ； ' o ^ ” ‘ Left:a-D-glucopyranosyl-( 1—2) 
A n A n 
V ^ o . V - ^ o M Right:P-D-fructopyranosyl-(l -^2) 
。“ [P-D-fmctofuranosyl-(l->2)]n-p-D-fmctoftiranoside 
Figure 1.1 Chemical structure of fructo-oligosaccharides (n=l-8) and inulin (8<n<58) 
(Franck, 2000) 
Transgalacto-oligosaccharides are not commonly occurred in nature but 
enzymatically synthesized by lactose by transglucosylation yielding a mixture of 
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oligosaccharides having a majority of P(1^6) and P(l—4) and some P(l—3) 
linkages with the degree of polymerisation from three to five (Crittenden, 1996). 
Lactulose, a semi-synthetic disaccharide, cannot be found in nature but can occur in 
heat-treated milk product by the isomerisation of lactose to form galactosyl 
P-(l->4)fructose (Montgomery and Hudson, 1929). 
The prebiotic potentials of other carbohydrates candidates like xylo-oligosaccharides, 
oligo-dextrans and sugar alcohols require further investigations to be confirmed. 
1.3 The intestinal microflora 
Human gut is a complex microbial ecosystem that is relatively stable over time 
(Franks et a!., 1998). There are about 10" bacteria per gram of gut contents and has 
as many as 400 different bacterial species in each healthy individual, usually referred 
as normal commensal microflora (van der Waaij et a/.，1994). The colonic bacterial 
population is important to the human health as it is involved in nutrition, 
pathogenesis and immunology of the host (van der Waaij et al., 1994). When there 
are any environmental changes in the gut, homeostatic reactions will restore the 
relationships that pre-existed among the bacterial populations forming the 
community (Harmsen and Welling, 2002). The normal commensal microflora found 
in a healthy person is dominated by strictly anaerobic species such as: Bacteroides 
spp., Fusohacterium spp., Bifidobacterium spp., Eubacterhmi spp. and 
Pwpionibacterium spp., which account for approximately 99% of the total human 
colonic microflora (Hill, 1995a). Figure 1.2 shows the generalised predominant 
bacterial genera with their potential harmful or beneficial effects found in the human 
colon. The colonic microbial composition in each individual depends on the dietary 
habits, progressive changes (aging or under stress) and intake of medications, etc. 
(Topping and Clifton, 2001). 
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Figure 1.2 The predominant groups of colonic bacteria, with potential harmful or 
beneficial effects to the human health (Salminen et al., 1998). * The numerical 
number in the vertical line denotes the logarithm of the number of colony-forming 
units wet feces 
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1.3.1 Bacteroides 
Bacteroide is a Gram-negative rod, anaerobic (with a relatively high tolerance for 
oxygen), saccharolytic bacterial genus (Gibson and Macfarlane, 1995). Bacteroide is 
one of the most dominant genera in the human colon, which account for 
approximately 30% of the total colonic bacteria (Salyers, 1984). During colonic 
fermentation, Bacteroides produce acetate, succinate and propionate as the 
fermentation products (Holdeman et al, 1977). The detailed metabolism of 
Bacteroides will be discussed in section 1.4.1.1. 
1.3.2 Bifidobacteria 
Bifidobacierium is a Gram-positive rod, strictly anaerobic, saccharolytic bacterial 
genus (Tamime et al., 1995). The amount of Bifidobacteria accounts for 
approximately 25% of the total microbes found in the healthy adult human colon, 
depending on the age, diet and ways of living (Mitsuoka, 1984). During colonic 
fermentation, Bifidobacteria produce acetate and lactate from carbohydrate 
substrates, typically in the molar ratio of 3:2, together with formate (Hawksworth et 
al., 1971). The detailed metabolism of Bifidobacteria will be discussed in section 
1.4.1.2. 
1.3.3 Clostridia 
Clostridium is a Gram-positive rod, anaerobic, saccharolytic and amino acid 
fermenting bacterial genus (Gibson and Macfarlane, 1995). The concentration of 
Clostridia in an adult human colon ranged from 3.3-13.1 logio per gram of dry 
weight feces depending on the health status and dietary habits (Salminen et al., 1998). 
During colonic fermentation, a range of products: acetate, propionate, butyrate, 
lactate as well as ethanol are produced by CIostrididL (van der Waaij, 1989). The 
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detailed metabolism of Clostridia will be discussed in section 1.4.1.3. 
1.3.4 Lactobacilli 
Lactobacillus, which is defined as rod-shape lactic acid bacteria (LAB), is the largest 
genus member of lactic acid bacteria (Orla-Jensen, 1919). Lactobacillus is a 
Gram-positive, microaerophilic, saccharolytic bacterial genus and is the most 
acid-tolerant genus among the lactic acid bacteria (Kashket, 1987). Up till now, eight 
species of Lactobacilli have been recognized (Satokari et al., 2003). Lactobacilli are 
divided into three groups (I, II and III) according to their physiological 
characteristics (table 1.1). The number of Lactobacilli found in a healthy adult 
human is about 3.6-12.5 logio per gram of dry weight feces (Aries, 1969). The 
detailed metabolism of Lactobacilli will be discussed in section 1.4.1.4. 
Table 1.1 Divisions of the genus Lactobacilli (Kandler and Weiss, 1986; Sharpe, 
1981) 
Character Group I: Group II: Group III： 
Obligatory Facultative Obligatory 
homofermentative heterofermentative heterofermentative 
Pentose fermentation - + + 
CO2 from glucose - - + 
FDP* aldolase + + _ 
Phosphoketolase + + 
Typical example L salivarius L casei L. brevis 
*FDP: fructose-1,6-diphosphate; L. \ Lactobacillus,, +: present; absent 
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1.4 Bacterial colonic fermentation 
Some dietary components (also known as colonic food) escape of the digestion and 
absorption that occur in the upper gastrointestinal tract. These components can reach 
the colon as substrates for the endogenous bacterial fermentation and thus offer 
energy to the bacteria and the host (Roberfroid, 2000). Since the colonic bacterial 
cells are capable of secreting hydrolases that are able to digest a wider range of 
substrates than the substrate specific intestinal mucosal enzymes found in the human 
gastrointestinal tract, fermentation of these indigestible materials by the colonic 
bacteria would provide sufficient energy for microbial growth and cellular 
maintenance in the host (Topping and Clifton, 2001). Most intestinal microbes prefer 
to use carbohydrates as their energy source for saccharolytic fermentation; however, 
certain types of microorganisms like Clostridia depend on protein fermentation 
(putrefaction) for energy (Gibson and Roberfroid, 1995). Protein breakdown and 
amino fermentation in the colon would increase if the availability of fermentable 
carbohydrates decreases (figure 1.3). Some colonic bacteria grow on the fermentative 
intermediates such as lactate, succinate, formate and ethanol, produced by other 
bacteria and eventually transform them into short-chain fatty acids and gases such as 
hydrogen and carbon dioxide (Macfarlane and Gibson, 1995). 
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Figure 1.3 Physiological effects of protein breakdown and amino fermentation in the 
large intestine (Adapted from Macfarlane and Macfarlane, 2003 a) 
1.4.1 Carbohydrates metabolism in colonic bacteria 
All of the major colonic bacteria such as Bacteroides and Propionibacteria except 
Bifidobacteria can ferment glucose to pyruvate via the Embden-Meyerhof (E-M) 
pathway, while other hexoses such as mannose, galactose and fructose enter the 
major pathways at different levels of phosphorylation for metabolism (Hill, 1995b). 
The colonic bacteria can also ferment pentoses through the phosphorylation and 
conversion into ribulose-5-phosphate or xylulose-5-phosphate by epimerase or 
isomerase, which in turn enter the 6-phosphogluconate/ phosphoketolase (6-PG/PK) 
pathway for metabolism (Kandler, 1983) Figure 1.4 shows the typical bacterial 
carbohydrates metabolism through the Embden-Meyerhof (E-M) and 
6-phosphogluconate/ phosphoketolase (6-PG/PK) pathways except Bifidobacteria. 
The catabolism of hexoses by Bifidobacteria follows a unique pathway known as the 
fructose 6-phosphate (F6P) shunt, with a characteristic key enzyme fructose 
6-phosphate phosphoketolase (F6PPK), which converts F6P to acetyl phosphate and 
erythrose 4-phosphate (Scardovi, 1965). The characteristic step that the bifidum 
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pathway differs from the 6-PG/PK pathway is the absence of 6-phosphogluconate as 
intermediate after the phosphoketolase step because of the absence of aldolase and 
glucose-6-phosphate dehydrogenase (Gottschalk, 1986). Bifidobacteria can utilize 
pentoses by the phosphorylation and convert them into ribulose-5-phosphate or 
xylulose-5-phosphate using epimerase or isomerase, which in turn enter the fructose 
6-phosphate (F6P) shunt for metabolism (de Vries and Stouthamer, 1967). 
During carbohydrates fermentation, pyruvate is formed and further metabolized 
through various pathways and produced different products (short-chain fatty acids), 
which are the characteristic of particular bacteria and serve as a biochemical way for 
identification (figure 1.4) (Anderson and Wood, 1969). 
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Figure 1.4 Typical bacterial metabolism of carbohydrates through Embden-Meyerhof 
(E-M)* and 6-phosphogluconate/ phosphoketolase (6-PG/PK)^ pathways except 
Bifidobacteria. Pyruvate metabolism pathways are the characteristic of particular 
organisms (Yebra and Martinez, 2002; Axelsson, 1998; Dawes and Large, 1982; 
London and Chace, 1977) 
Key for figure 1.4. Fru: Fructose; Gal: Galactose; Glu: Glucose; Man: Mannitol; P: 
Phosphate; Rib: Ribulose; Sor: Sorbitol; Tag: Tagatose; Xyl: Xylulose 
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1.4.1.1 Carbohydrates metabolism in Bacteroides 
Like most of the other colonic bacteria, glucose intakes are fermented by Bacteroides 
through the E-M pathway to produce pyruvate. On one hand, Bacteroides utilize 
pyruvate through the decarboxylation to yield acetate. On the other hand, 
Bacteroides are able to convert pyruvate to propionate and succinate by a series of 
carboxylation and reduction, as the final products (Macy and Probst, 1979). The 
main products of carbohydrate fermentation are acetate and succinate at normal 
growth rate, while Bacteroides increase its propionate production and decrease its 
succinate production when having a relatively slower growth rate (Kotarski and 
Salyers, 1981). 
1.4.1.2 Carbohydrates metabolism in Bifidobacteria 
Bifidobacteria utilize pyruvate produced as an intermediate in the 
fructose-6-phosphate shunt by two routes: reduction of pyruvate to lactate by the 
lactate dehydrogenase and breakdown of pyruvate into acetyl phosphate and formate 
by phosphoroclastic enzyme (de Vries and Stouthamer, 1967). Under limited carbon 
condition, Bifidobacteria produce mainly acetate and formate as fermentation 
products, however, acetate and lactate are produced when carbohydrate supply is in 
excess (Macfarlane and Macfarlane, 2003b). 
1.4.1.3 Carbohydrates metabolism in Clostridia 
The majority of Clostridia except C. malenominatum and C. sporosphaeroides in the 
human colon are saccharolytic, which utilize glucose through the E-M pathway 
(Hopkins and Macfarlane, 2002). ClostrididL utilize pyruvate to form butyrate as the 
main product as well as acetate, propionate and lactate (van der Waaij, 1989). 
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1.4.1.4 Carbohydrates metabolism in Lactohacilli 
Lactobacilli are either homofermentative (lactic acid as the main product) or 
heterofermentative (lactic acid, carbon dioxide, ethanol and/or acetic acid as products 
in equimolar amounts) (Tannock, 2004). Obligatory and facultative 
homofermenative Lactobacilli ferment hexose through the E-M pathway, under 
excess sugar and limited oxygen conditions and pyruvate is reduced to lactic acid by 
the lactate dehydrogenase (Axelsson, 1998). Facultative and obligatory 
heterofermentative Lactobacilli ferment hexose through the 6-PG/PK pathway, in 
which phosphoketolases split xylulose 5-phosphate (X5P) into GAP and acetyl 
phosphate. GAP is metabolized as the same way in the E-M pathway to produce 
lactic acid while acetyl phosphate is cleaved into acetyl CoA and acetaldehyde to 
yield carbon dioxide, ethanol and/ or acetic acid (Biavati et al, 2000). 
1.5 Health benefits of prebiotics 
The well-established effects of prebiotics have been recently reviewed (Gray, 2003). 
They include non-digestibility, low energy value, stool bulking effect as well as 
modulation of the gut microflora by promoting Bifidobacteria and Lactobacilli and 
suppressing Clostridia growth (Tuohy et al., 2001; Roberfroid et aL, 1998; Salminen 
et aL, 1998; Gibson and Roberfroid, 1995). Clostridia and other putrefactive bacteria 
produce toxic substances such as ammonia, phenols, amines and indoles during 
colonic fermentation, which pose potential harmful effects to cellular tissues if any of 
these toxins, even at low levels, escape the detoxification mechanisms in the liver 
(Ouwehand et aL, 2005). Clostridium is also regarded as a bioconverter of dietary 
lipids into carcinogenic substances such as diacylglycerol (DAG), which activates 
protein kinase C, a potent stimulator of mucosal cell proliferation (Morotomi et al., 
1990). Since the prebiotics have the ability to selectively stimulate the growth of 
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Bifidobacteria and Lactobacilli populations, which can thereby suppress the number 
of health-deteriorating bacteria in the colon by intensive nutrient and space 
competitions (Gibson, 1998). Also, during bacterial fermentation of prebiotics, 
short-chain fatty acids (acetate, propionate and butyrate) are the principal metabolic 
end products (Scheppach et al, 2001). The production of the short-chain fatty acids 
would therefore lower the colonic pH and thus create an environment favouring the 
growth of acid-tolerant species like Bifidobacteria and Lactobacilli and suppress 
other microbial communities in the colon (Walker et al., 2005; Gibson and Wang, 
1994a). Other inhibitory effects towards bacterial pathogens by Bifidobacteria and 
Lactobacilli based on the stimulations of the non-specific host defense mechanisms 
and/ or specific immune response and resulted in a gastroenteritis protection (figure 
1.5). There are also promising evidences showing the hypolipidemia and increase in 
cation (mainly calcium and iron) bioavailability effects of prebiotics (Jackson et al., 
1999; Delzenne and Kok, 1999; van den Heuvel et al., 1999; Coudray et al., 1997). 
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Figure 1.5 The modulation of immune response by Bifidobacteria and Lactobacilli 
against pathogens in colon (Adapted from Rastall et al., 2005) 
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1.6 Metabolites of fermentation: Short-chain fatty acids (SCFAs) 
The amounts and types of short-chain fatty acid (SCFA) production by the colonic 
bacteria in healthy individuals are regulated by different factors: substrate availability, 
bacterial species composition of the microbiota and intestinal transit time (Topping 
and Clifton, 2001). More than 60% of the short-chain fatty acid uptake is performed 
by simple diffusion in the colon, in which short-chain fatty acids are protonated by 
the hydration of luminal CO2, while the rest of the short-chain fatty acid uptake 
involves the co-transportation of Na+ or K+ ions (Fleming et al, 1991; McNeil and 
Cummings, 1978). More than 95% of the short-chain fatty acids formed by the 
intestinal bacteria are absorbed and metabolised by the host, which account for up to 
90/0 of the host energy requirements (Cummings, 1995; Hume, 1995). There is a wide 
range of physiological functions of SCFAs in the body. The concentration of SCFAs 
in the body ranges from 100 to 180 mmol per kilogram of gut content, in which the 
concentration of SCFAs in the caecal area is doubled than those found in the 
recto-sigmoid area (Salminen et al., 1998). 
Acetate is the main SCFA formed during colonic fermentation followed by 
propionate and butyrate and their molar ratio is usually about 60: 20: 20, respectively 
(Cummings et al., 1987). The short-chain fatty acids profile in each individual varies 
with his or her dietary habit, for example pectin and guar gum intake boost the 
acetate and propionate production, respectively, and the bacterial profile in the colon 
(Mclntyre el al, 1991; Cheng etal., 1987). 
Acetate is taken up by the epithelium and metabolised generally in various parts of 
the body such as muscles, kidney, heart and brain through the transportation of blood, 
while propionate is largely cleared by the liver where it may reduce cholesterol levels 
in blood (Gibson et al., 2003). Butyrate is the most preferable source of energy for 
the colonocytes metabolism compared with acetate, propionate, and even glucose or 
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glutamine, by promoting a normal phenotype in colonocytes (Roediger, 1980 and 
1995; Pradad, 1980). Butyrate has also been shown to arrest cell growth in early G! 
phase by increasing p21 production, which helps to block aberrant cell cycle division 
that is responsible for the carcinogenic processes (figure 1.6). Another important 
mechanism of butyrate action is on histone acetylation, where inhibition of this 
process enables hyperacetylation of histories to occur, which facilitates the access of 
the DNA repair enzymes (Kruh et al., 1995). Therefore it is desirable to increase the 
concentration level of butyrate in the large intestine. Although Bifidobacteria and 
lactic acid bacteria are not butyrate producers, the lactate produced by these bacteria 
can be acted as a precursor for butyrate synthesis in the human intestine (Bourriaud 
et al., 2005). Megasphaera elsdenii is a normal constituent in the human colonic 
microflora and it is capable of metabolising lactate into butyrate (Counotte et al., 
1981). 
. . Cell Division Daughter Cell 
^ ^ ^ Proliferation i 
G2 phase f Differentiation t J Gi phase 
S phase Butyrate 丁 p21 production 
Figure 1.6 Butyrate induces p21 production to block cell cycle in Gi phase (Adapted 
from Pradad and Sinha, 1976) 
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1.7 Applications of prebiotics as functional food ingredients 
Prebiotics such as inulin and fructo-oligosaccharides can be used to improve the 
organoleptic quality and improve the nutritional composition of wide categories of 
food products (Franck and Coussement, 1997). For example, inulin has the ability to 
form inulin microcrystals when sheered in water or milk, in which the microcrystals 
cannot be perceived in the mouth but can provide a fat-like mouth-feel when interact 
to form a smooth creamy texture with spreadability. Therefore inulin is commonly 
used as a fat replacer in table spreads and butter products as well as dairy products 
and desserts (Kaur and Gupta, 2002). Fructo-oligosaccharides also have the 
technological properties that are closely related to sugar and glucose syrup, which 
account for 35% sweetness of sucrose (Crittenden, 1996). Fructo-oligosaccharides 
are therefore usually used in combination with high intensity sweeteners with 
synergism to replace sugars in sugar-reduced products fit for diabetic patients and 
masked the after-taste of aspartame or acesulfam K (Weidmann and Jager, 1997). 
The sweetness of transgalacto-oligosaccharides is approximately one-third of that of 
sucrose and can also be used in replacing certain amount of sugar in food products 
(Schotermain and Timmermans, 2000). Transgalacto-oligosaccharides cannot be 
digested in the upper gastro-intestinal tract and be regarded as soluble dietary fiber, 
which can be added into the fiber-rich products as functional food products 
(Tomomatsu, 1994). 
Lactulose has a taste enhancing property as well as 60-80% relative sweetness to 
sucrose, therefore can be used as a food additive to substitute sugar in health 
products (Battermann, 1997). 
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1.8 Methodology for evaluating prebiotics 
There are a number of approaches to evaluate the potential advantages of prebiotics 
to regulate the human gut bacterial populations. The in vitro inoculum can be human 
intestinal pure bacterial culture to reflect the metabolism in mono-culture (Wang and 
Gibson, 1993). Alternatively, fecal slurries (reflecting microflora in the distal colon) 
or gastrointestinal residues from sudden dead victims (reflecting microflora in the 
proximal colon) can also be used in in vitro studies (Macfarlane et al., 1998). In vitro 
studies, oral administration of tested substrates to the human microflora-associated 
rats for in vivo studies as well as human clinical trials provide useful indicators for 
prebiotic evaluation (Rowland and Tanaka, 1993; Moore et al., 2003). 
1.8.1 In vivo fermentation study 
Since rats and mice do not have similar colonic bacterial community as that in 
humans, germ-free rats inoculated with human fecal microflora, known as human 
microflora-associated rats is commonly used to investigate the prebiotic properties of 
the substrate for in vivo study (Rowland and Tanaka, 1993). 
1.8.2 Human clinical study 
Potential prebiotics candidates proved to have no toxicological effects are given to 
the human volunteers, within the targeted age group with no previous gut disorder 
history and have not taken any antibiotics for at least 3 months before the study, in 
their controlled or free diet either as a dietary supplement or fortified in the food 
products for a period of time to monitor the changes in stool frequency/ consistency, 
colonic bacterial pattern and short-chain fatty acids production (Moore et al, 2003; 
Moro et al., 2003; Tuohy et al, 2001). Some of the studies invited colostomy 
subjects to investigate the compositional changes in the colostomy effluent, 
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reflecting the proximal colon, which is often difficult to be assessed in the healthy 
human study (Ahmed et al, 2000). 
1.8.3 In vitro fermentation study 
In vitro fermentation study inoculated with human fecal/ intestinal residue slurry is 
one of the most useful tools for modelling the ecology and metabolic activities of the 
human colonic bacteria since it counteracts the expensiveness and uncertain 
toxicology for human consumption in human clinical trial and gut anatomy as well as 
rodent practice differences in animal models (Rastall and Gibson, 2002; Macfarlane 
et al, 1998). Moreover, inoculation of pure culture (even in a mixture of pure culture) 
cannot induce such an intensive bacterial competition that occurred in human colon 
and thus cannot truly identify the selectivity of fermentation of a particular substrate 
(Cummings and Macfarlane, 1991). 
The human large intestine is known to be a heterogeneous environment, in which the 
proximal and distal parts of the colon are quite distinct by their anatomical, 
microbiological and environmental conditions (Macfarlane and Macfarlane, 2003a). 
Once the colonic food enters the proximal colon, indigenous bacteria rapidly utilize 
the available simple carbon and nitrogen sources and breakdown the complex dietary 
carbohydrates, lipids and proteins. This resulted in a relatively high level of substrate 
availability in the proximal region of the colon. However, bacterial cell population 
densities increase distally through the colon (Macfarlane et al., 1992). Due to 
intensive colonic bacterial fermentation, organic acids are produced; pH is reduced to 
about 5.5 in the proximal colon when compared to pH 6.8-7.0 in the distal colon 
(Cummings et al., 1987). Therefore in vitro fecal batch culture system provides a 
rapid and relative inexpensive way to have a preliminary assessment on the potential 
prebiotic candidates. Further investigation of the extent and site of prebiotic 
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fermentation can be done by a three-stage continuous fermentation system, which is 
able to reflect the proximal, transverse and distal conditions of the human colon and 
eventually human clinical studies (Wisker et al., 1998). 
1.9 Methods of bacterial enumeration 
Nowadays, a variety of techniques have been developed to study the bacterial content 
in human feces. Traditional selective culturing provides a straightforward approach 
to quantify different bacteria present in human feces (table 1.2). 
Table 1.2 Selective culture media for cultivating predominant groups of human 
colonic bacteria (Wang and Gibson, 1993) 
Target group Selective culture media 
Total anaerobes Wilkins-Chalgren agar 
Bacteroides Brucella agar + 75 mgr^ kanamycin + 5 mgl"^  haemin + 10 mll"^  
phylloquinone + 75 mgl] vancomycin + 50 mll"^  laked horse blood 
Bifidobacteria Beeren's agar (Columbia agar + Sgl"^  glucose + 0.5 gV^ cysteine 
HCl + 0.5 gl] propionic acid) 
Clostridia Reinforced Clostridia agar + 8 mgl"^  colistin + 8 mgl"' novobiocin 
Lactobacilli Rogosa agar + 1.32 mir^ glacial acetic acid 
However, the selective agars and the optimal growth conditions are only available for 
a small proportion of the most numerically dominant species and less than 50% of 
the human gut bacteria are non-cultivable by the existing techniques (Wilson and 
Blitchington, 1996). Nowadays, culture-independent molecular level techniques are 
commonly applied in the identification and enumeration of human fecal flora. 
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Bacterial genus or even species specific 16S rRNA-based oligonucleotides were 
typically used either as probes in fluorescent in situ hybridisation (FISH) or primers 
and probes in polymerase chain reaction (PCR) for bacterial analysis (Harmie et al., 
2000; Matsuki et al” 1999). Practically, it is still not feasible to demonstrate each of 
the colonic microbial changes during fermentation by the current methods. However, 
it is possible to preliminary assess the prebiotic potential of the selected substrates to 
regulate colonic bacterial composition by examining the populations of particular 
bacterial genus believed to be indicative of human colonic health using molecular 
techniques such as fluorescent in situ hybridisation (FISH) (Harmsen and Welling, 
2002; Wang and Gibson, 1993). 
1.9.1 Fluorescent in situ hybridisation 
In fluorescent in situ hybridisation, the DNA oligonucleotide probe has to be linked 
with a fluorophore, its photons absorb certain wavelength of light and emit light with 
longer wavelength, at the 5' and/or 3' end directly by chemical conjugation or 
indirectly with a non-fluorescent molecule followed by fluorophores incubation to 
facilitate the analysis (Harmsen and Welling, 2002). Figure 1.7a-b show the chemical 
structures of Cy3 and FITC fluorophores commonly used in FISH. There are various 
types of fluorophores with different excitation and emission profiles across the light 
spectrum that can be chosen to link with the oligonucleotide probe (table 1.3). 
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Figure 1.7 Chemical structures of fluorophores (a) Cy3 (b) FITC 
Table 1.3 Examples of fluorophores with ultraviolet, violet, blue, green, yellow and 
red excitation and emission spectral profiles (www.microscopyu.com) 
Fluorophores Excitation spectral Emission spectral 
Acridine Blue, Cascade Blue, Ultraviolet Blue 
Alexa Fluor 405, Uranine B Violet Blue Green 
FITC, Acridine orange, Acrdine yellow. Blue Green 
Acrdine Red, Cy3, Eosin, Rhodamine, Green Orange Yellow 
Aminoactinomycin D, Cy3.5, Neutral Red, Yellow Orange 
Alexa Fluor 633, Cy5 Red Dark Red 
In each fluorescent in situ hybridisation protocol, a single (FISH) or multiple types of 
probes (multicolour FISH) can be added. However, in deciding the number of types 
of probes used in multicolour FISH, it depends on the number of fluorochromes 
whose fluorescent excitation and emission spectra can be clearly differentiated 
visually (Takada et al., 2004). The resultant fluorescently labelled cells can be 
enumerated by fluorescent microscopy or flow cytometry (Langendijk et al, 1995). 
In both fluorescent microscope and flow cytometer, they are equipped with several 
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optical blocks, each have a set of excitation filter, dichromatic beamsplitter and 
emission filter with specific wavelengths for transmission, for different fluorophores 
having different excitation and emission spectra (figure 1.8). Once the photons of the 
fluorophores are excited by specific wavelength of light, which transmitted through 
the excitation filter and reflected by the beam-splitter, they will emit light with a 
longer wavelength, which will be transmitted through the beam-splitter and the 
emission filter and will be detected visually in fluorescent microscope or 
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Figure 1.8 An optical block included an excitation filter, a dichromatic beam-splitter 
and an emission filter (Adapted from www.microscopyu.com) 
1.9.2 Bacterial enumeration by automatic image analysis 
Enumeration of bacterial cells manually through the fluorescent microscope is a 
laborious and tedious task. Automatic quantification of bacterial cells present in the 
captured image by computer software is a more objective and less labour-intensive 
alternative. The function of this type of software such as CellC is similar to the 
commercial ones, which is capable of enumerating the total bacterial number and the 
relative abundance of specific genus or species present in the sample, double stained 
with 4'-6-diamino-2-phenylindole (DAPI) and genus/ species-specific probe 
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(fluorescent in situ hybridisation (FISH)) by capturing the computer images at the 
same position with different optical blocks (Jansen et al., 1999) (figure 1.9). This 
software is able to count individual bacteria by splitting the bacterial clutters from 
each other in the analysed image. When compared the total bacterial counts by CellC 
with the manual enumeration, a correlation greater than 0.98 has been revealed 
(Selinummi et al., 2005). The detailed layout of CellC software for total and specific 
cell enumerations will be described in section 2.7.1. 
1.10 Sugar alcohols 
1.10.1 Sugar alcohols and their functions 
A sugar alcohol (also known as polyol) is defined as a hydrogenated form of 
carbohydrates, in which its carbonyl group has been reduced to a hydroxy 1 group. 
They naturally occur in nature or can be produced industrially by catalytic 
hydrogenation of carbohydrates (Kato and Moskowitz, 2001). Since sugar alcohols 
do not promote tooth decay, they have particular applications in tooth-friendly food 
products (Dorr and Ettle, 1996). Xylitol and sorbitol are the commonly used sugar 
alcohols in chewing gums and oral care products such as toothpaste and mouthwash 
because of their cooling effects (endothermic property) to give the perception of mint 
and the health claim of reducing plaque levels and caries increment (Soederling et al., 
1988). Sugar alcohols are also commonly used as food additives in combination with 
intense artificial sweeteners to counteract their relative low sweetness for replacing 
sucrose in food, beverages and confectioneries (table 1.4). The daily dietary intake of 
each sugar alcohol has not been intensively studied but it is suggested that the daily 
consumption of sorbitol as food ingredient by a healthy human adult in the USA is 
about 200 mg (Wang and van Eys, 1981). 
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Table 1.4 Relative sweetness to sucrose and cooling effect of typical sugar alcohols 
(Natah et aL, 1997) 
Sugar alcohol Relative sweetness Cooling effect 
(Sucrose = 1) 
Xylitol 1.0 Very cool 
Sorbitol 0.6 Cool 
Mannitol 0.7 Cool 
Lactitol 0.4 Slightly cool 
The prebiotic potentials of four different sugar alcohols commonly consumed in our 
diet: xylitol (five-carbon monomeric, hydrogenated from xylose, commonly found in 
cauliflowers, plums and raspberries), sorbitol (six-carbon monomeric, hydrogenated 
from glucose, commonly found in pears, prunes and peaches), mannitol (six-carbon 
monomeric, hydrogenated from mannose, commonly found in celeries, mushrooms 
and asparagus) and lactitol (dimeric hydrogenated from lactose, cannot be found in 
nature) were evaluated in this study (Wang and van Eys, 1981) (figure 1.9). 
24 
OH 
OH OH QH 
Y r 
h Z S ^ I 1 






OH QH y ^ 
I 1 HoZ ^ ^ ^，叫 / \H 
OH OH HO 
OH 
Mannitol Lactitol 
Figure 1.9 Chemical structures of xylitol, sorbitol, mannitol and lactitol 
1.10.2 Digestion and absorption of sugar alcohols 
The hydrogenated structures of mono- and disaccharide sugar alcohols increase the 
resistance of their digestion and absorption, compared with that of the original 
saccharides (Oku and Nakamura, 2002). Monosaccharide sugar alcohols are solely 
absorbed by passive diffusion in the human small intestine after ingestion, as there is 
no specific transport system for sugar alcohol absorption. Therefore, they enter the 
blood circulation less efficiently than glucose and fructose molecules present in the 
small intestine (Wolever et al,, 2002). Lactitol can neither be digested nor absorbed 
in the upper gastrointestinal tract, as the enzyme B-galactosidase for lactitol 
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digestions is not found in humans (Kontula et al., 1999, Olinger and Pepper, 2001). 
The percentage of sugar alcohol absorption in the human small intestine ranges from 
0% for lactitol to nearly 50% for sorbitol, mannitol and xylitol (Langkilde et al, 
1994). Because of the mal-absorption of the polyols, they all give a lower maximum 
nutritional calorie (sorbitol: 2.6 kcalg"^; mannitol: 1.6 kcalg'^; xylitol: 2.9 kcalg'^ 
lactitol: 2.0 kcalg-i) than that of the digestible and absorbable carbohydrates (4.0 
kcalg-i), depending on their fermentability in the human colon. 
1.10.3 Metabolism of sugar alcohols in humans 
The absorbed monosaccharide sugar alcohols are further metabolised to yield energy. 
The initial metabolism of sorbitol and mannitol take place in the liver. Sorbitol and 
mannitol are mainly converted to fructose and enter the pentose-phosphate pathway 
for metabolism by the liver cells. Part of the absorbed sorbitol and mannitol are 
converted to glucose, which subsequently either enter the Embden-Meyerhof (E-M) 
pathway for metabolism or convert to glycogen for temporary storage in the muscles 
(Allison, 1979). The metabolism of xylitol follows the pentose phosphate pathway, in 
which xylitol is converted to xylulose and subsequent to citric acid cycle for energy 
production (Williams et al,, 1987). 
1.10.4 Adverse effect of sugar alcohols 
Generally, no toxicological effects have been found in sugar alcohols consumption 
(WHO/FAO, 1977). However, due to the slow absorption rate of the sugar alcohols, 
the resulting osmotic imbalance are considered to be the cause of abdominal 
cramping, abdominal bloating and diarrhea after large amounts of polyols 
consumption (Culbert et al,, 1986) Human adult can normally well-tolerate with 
about 50 grams per day of lactitol, xylitol and sorbitol and about 20 grams per day of 
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mannitol (Wang and van Eys, 1981). However, the acceptable daily intake (ADI) of 
xylitol, mannitol, sorbitol and lactitol is not specified on the basis of the available 
data (WHO Food additive series, 1983, 1974 and 1966). With continued exposure to 
different sugar alcohols, digestive tolerance can be developed (Foerster, 1978). 
1.11 Fermentation of sugar alcohols in colonic bacteria 
Sugar alcohols that escape the digestion and absorption in the small intestine, can go 
along the intestinal tract and reach the large intestine for bacterial fermentation, like 
those hexoses and pentoses yielding short chain fatty acids (SCFAs) as the principal 
end products (Macfarlane and Gibson, 1995; Merli et al., 1992; Beaugerie et al., 
1990; Koellreutter et aL, 1990) (figure 1.4). 
The metabolism of hexitol in bacteria is initiated by the phosphoenolpyruvate 
phosphotransferase system, which is a complex enzyme machinery and is used for 
the translocation of a sugar across the membrane with simultaneous phosphorylation, 
in this case it transports and phosphorylates the hexitol to hexitol phosphate (Postma 
et al, 1993). It is further converted to fructose-6-phosphate by the phosphate 
dehydrogenase and eventually enters the E-M pathway for metabolism (Yebra and 
Martinez, 2002). 
Similar to that of hexitol, the pentitol intake in bacteria is transported by the 
phosphoenolpyruvate phosphotransferase system that phosphorylates pentitol into 
pentitol phosphate. Specific dehydrogenase oxidizes the intermediate product into 
ketopentose phosphate, eventually to xylulose-5-P and enters the 
6-phosphogluconate/ phosphoketolase (6-PG/PK) pathway for metabolism (London 
and Chace, 1977). 
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1.12 Project objectives 
The present study investigated the in vitro fecal bacterial fermentation of four 
different sugar alcohols commonly consumed in human diets: xylitol, sorbitol, 
mannitol and lactitol. Their prebiotic potentials, including increasing microbial 
populations as determined by FISH, fermentability in terms of dry/ organic matter 
disappearance (DMD/ OMD) percentage and short-chain fatty acid profile, were 
compared. Fructo-oligosacchrides (FOS) (a known prebiotics) was used as a positive 
control in this study. The most potent prebiotic sugar alcohol found was further 
evaluated and compared with FOS in a three-stage continuous fermentation system. 
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Chapter 2. Materials and Methods 
2.1 Materials 
All the sugar alcohols and FOS used as substrates were from Wako Pure Chemical 
Industries (Osaka, Japan) and all the chemicals were supplied by Sigma-Aldrich 
Company Ltd. (Dorset, United Kingdom) unless otherwise stated. 
2.2 Static batch culture fermentation 
2.2.1 Substrate preparation 
Each substrate (0.5 g) was weighed into individual 100 ml fermentation vessels 
modified from Schott reagent bottles (figure 2.1)，each containing 39 ml of 0.2 M 
autoclaved phosphate buffer solution (PBS), which contained (gl"^): sodium 
phosphate, 5.254; sodium dihydrogen orthophosphate, 25.43. A reagent blank control 
containing only the PBS was set up accordingly. The pH of the sample and the 
control was adjusted to 6.8 by using 2 N NaOH. The reagent bottles containing the 
substrates and the control were flushed with oxygen-free argon for 1 minute and 
placed in a 37。C shaker with mild agitation overnight. Sterile enzyme additive 
Oxyrase (Oxyrase®, Mansfield, USA) (1 ml), used for producing an anaerobic 
environment, was added to the substrate mixture 2 hours before the inoculation with 
human fecal slurry. 
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Figure 2.1 Fermentation vessel used for batch culture 24-hour in vitro fermentation 
2.2.2 Human fecal inoculum preparation 
A 25% (w/v) fecal slurry was prepared by using fresh human feces from 3 healthy 
Chinese donors (2 males and 1 female) who had consumed a non-specific Chinese 
diet and had not taken any antibiotics for the past 3 months with no history of 
gastrointestinal diseases prior to the study. Individual fresh feces (about 25 g each) 
was transferred immediately into an autoclaved and pre-weighed 100 ml 
fermentation vessel containing 49 ml PBS at pH 6.8 and oxyrase (1 ml) that had been 
flushed with oxygen-free argon for 1 minute prior to collection. The fermentation 
vessels containing human feces were tightly closed and wrapped with parafilm 
before subsequent fecal slurry preparation. In a laminar flow hood, the fecal slurry 
was diluted by blending with autoclaved 0.2 MPBS in a cup blender for 50 seconds, 
followed by homogenisation at 10,000 rpm for 1 minute by the use of a high-speed 
homogeniser (Polytron PT3000, Switzerland). After filtering through 3 layers of 
filtration net, 10 ml of homogenised fecal sample was inoculated into the 
fermentation vessels containing the sugar alcohols and reagent blank at 37°C. The 
head space of each fermentation vessels was flushed with oxygen-free argon for 1 
minute. All vessels were tightly closed and sealed with parafilm before incubating at 
37°C incubator for 24 hours with mild agitation. The fermentation broths were 
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sampled at 0 and after 24 hour of the fermentation for bacterial enumeration (section 
2.7) and SCFA (section 2.8) analysis. The pH of the fermentation slurry in each 
vessel was measured at 0 and after 24 hours of fermentation as well. The 
fermentation experiments were performed in triplicate for each substrate. 
2.3 Dry matter and organic matter disappearance in batch fermentation 
The remaining non-fermented residue after 24-hour batch culture fermentation from 
above was dried in a 120。C oven (Sheldon manufacturing Inc., Oregon, USA) to 
determine the residual dry matter (AOAC, 1990). The weighed dry matter was ashed 
in a 600°C muffle furnace (Cole-Parmer, Illinois, USA) overnight. The dry matter 
disappearance (DMD) percentage and organic matter disappearance (OMD) 
percentage are expressed as follows: 
[DMoriginal-(DM24-B24)] 
DMD(%) = X100% (1) 
DMoriginal 
in which DMoriginai is the mean weight of dry matter of the substrate before 
fermentation; DM24 is the mean weight of dry matter of the non-fermented residue 
after 24 hours of fermentation; B24 is the mean weight of dry matter in the reagent 
blank after 24 hours of fermentation. 
[OM。r ig inal-(OM24-B24)] 
OMD(%) = X100% (2) 
OMoriginal 
in which OMonginai is the mean weight of organic matter (difference between weight 
of dry matter and weight of ash) of substrate before fermentation; O M 2 4 is the mean 
weight of organic matter of the non-fermented residue after 24 hours of fermentation; 
B24 is the mean weight of organic matter in the reagent blank after 24 hours of 
fermentation. 
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2.4 Determination of flow rate in the continuous fermentation system 
Fecal bacterial growth curve in batch culture system was determined by the similar 
procedures described in section 2.2. 
Table 2.1 An enriched medium used as the fermentation medium, the medium for 
fecal sample dilution and fecal collection medium at pH 6.8 
Chemical name Amount (gl"^) 
Bacto™ peptone (Becton, Dickinson and company, USA) 2 
Yeast extract (USB™, USA) 2 
Sodium chloride (Riedel-deHaen®, Germany) 0.1 
Potassium phosphate dibasic 0.04 
Potassium phosphate monobasic 0.04 
Magnesium sulphate hydrated (MgS04.7H20) (Ajax Chemicals, 0.01 
Australia) 
Calcium chloride dihydrate (APS Ajax Finechem, Australia) 0.007 
Sodium bicarbonate 2 
Cysteine-HC 丨 0.5 
Bile salts 0.5 
Tween 80 (Amresco®, USA) 2 
Hemin 0.05 
The fermentation broths were sampled, at 0 and after 8, 24 and 48 hours of 
fermentation, for total cell count enumeration (section 2.7). The fermentation 
experiments were performed in triplicate. The exponential growth in batch culture 
was determined by plotting the graph with concentration of bacterial population 
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against time. 
Under continuous fermentation, the specific growth rate is controlled by the dilution 
rate of the system. The dilution rate of the continuous fermentation system may thus 
only be operated below the maximum growth rate of the bacteria (Stanbury et al., 
1999). 
The flow of medium into the vessel (F) is related to the volume of the vessel (V) by 
the term of dilution rate, D, defined as 
D= F/V (3) 
in which F is the flow rate (mlh"^) and V is the volume (ml) 
The operating parameters of the three-stage continuous fermentation system (2.5.2) 
were determined. 
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2.5 Three-stage continuous fermentation culture system 
2.5.1 Initial set-up 
A three-stage continuous culture fermentation was carried out with an anaerobic 
continuous culture system previously described (Probert et al., 2004) with 
modifications (figure 2.2). The main body of the system consisted of three glass 
vessels (VI, V2 and V3) aligned in series, which mimics the environmental 
conditions found in the ascending, transverse and descending colon of humans, 
respectively. Vessels 1, 2 and 3 had an operating volume of 90 ml, 100 ml and 110 ml, 
respectively and were connected in between with 2.5 mm inner diameter silicon 
precision pump tubings (Cole Parmer, Illinois, USA). A L/S® Masterflex® pump 
(Cole Parmer, Illinois, USA) linked with 1.3 mm inner diameter silicon precision 
pump tubing (Cole Parmer, Illinois, USA) was located between the reservoir and VI , 
which controlled the rate of culture medium flowing into the system. The liquid flow 
from VI to V2 and sequentially from V2 to V3 was brought by overflow of liquid in 
each vessel. The culture medium from V3 was vented into the waste vessel to 
complete the system. The temperature of the circulator (PolyScience®, USA) was set 
at 37。C, in which water was circulated around the water jacket positioned outside 
each vessel to maintain a constant temperature for the system. Culture medium in 
each vessel was magnetically stirred on occasion to ensure equal distribution of the 
slurry. The pH of VI , V2 and V3 was maintained manually at 5.5, 6.2 and 6.8, 
respectively by the addition of 2 N NaOH or HCl as required. The whole system, 
including the medium reservoir and the three vessels, was flushed with oxygen-free 
nitrogen after sample taking and pH adjustment, to ensure the system was under 
anaerobic conditions. All openings in the system were closed tightly and wrapped 
with parafilm to prevent any gas leakage and microbial contamination. 
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Figure 2.2 Set up of the three-stage anaerobic continuous culture system 
2.5.2 Continuous fermentation 
Each sterile vessel (V1-V3) was three-fourth filled with autoclaved (121°C for 15 
minutes) enriched fermentation medium mentioned in table 2.1 at their respective pH 
5.5, 6.2 and 6.6. The remaining volume of each vessel was made up with 20% (w/v) 
freshly prepared human fecal slurry described in the section 2.2.2 and diluted with 
the fermentation medium at pH 6.2. Following fecal inoculation, the peristaltic pump 
was adjusted to give a flow rate at about 9.09 ml hour"^ and the system retention time 
of approximately 33 hours, which would result in a dilution rate less than the 
maximum growth rate of the fecal bacteria determined in section 2.4. In each of the 
fermentation, tested substrate (FOS or lactitol) was added at a concentration of 1% 
(w/v) in the reservoir with the fermentation medium at pH 5.5. A reagent blank 
35 
control containing only the fermentation medium at pH 5.5 was set up accordingly in 
the reservoir. After 0, 24 and 48 hours of inoculation, the fermentation broths were 
sampled from each vessel for subsequent bacterial (section 2.7) and short-chain fatty 
acid (section 2.8) analysis. 
2.6 Validation of fluorescent in situ hybridisation (FISH) method 
2.6.1 Oligonucleotide probes for FISH 
Genus-specific 16S (small ribosomal subunit) rRNA-targeted oligonucleotide probes 
(table 2.2) labelled with fluorochrome Cy3 or FITC linked to the 5' end of the DNA 
probe (Proligo, Colorado, USA) were used for fluorescent in situ hybridisation. The 
total cell counts were enumerated using 4',6-diamidino-2-phenylindole (DAPI) 
(Fluka, Seelze, Germany) which is a fluorescent nucleic acid stain that binds strongly 
to DNA of all bacteria. The dried oligonucleotide probes and DAPI were diluted with 
autoclaved ultra-pure water to a concentration of 50 ngui] and 500 ng|j,r\ 
respectively and stored at -20°C and 4°C correspondingly at dark for further use. 
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Table 2.2 Genetic probes and sequences used for predominant groups of intestinal 
bacteria 
Probe target Name of probes Sequence (5'- 3') 
Bacteroides! Prevotella Bac 303 CCAATGTGGGGGACCTT' 
Bifidobacteria Bif 164 CATCCGGCATTACCACCC' 
Clostridium perfHngem/ His 150 TTATGCGGTATTAATCT(C/T)CCTTT' 
histolyticum subgroup 
Lactobacilli/ Enterococci Lab 158 GGTATTAGC A(T/C)CTGTTTCC A^ 
group 
\Manz et al., 1996), ^Langendijk et al, 1995), ^(Franks et al., 1998), ^Harmsen et 
al., 1996) 
2.6.2 Cultivation of pure human intestinal bacterial culture 
Three freeze-dried human intestinal pure culture bacterial species (table 2.3) obtained 
from Japan Collection of Microorganisms (JCM) were chosen for oligonucleotide 
probes validation. Bacterial cultures were hydrated with 0.5 ml appropriate 
autoclaved media (Oxoid, Hampshire, UK). The hydrated culture was evenly mixed 
with the appropriate autoclaved media containing 30% agar and cultivated 
anaerobically in plates at the particular temperature for individual bacterial species 
(table 2.3) in an anaerobic jar with a CO2 gas generating kit (Oxoid, Hampshire, UK) 
for 3 days. Single colony was selected to subculture in the appropriate autoclaved 
medium broth (50 ml) under same conditions. Bacterial culture (0.5 ml) was 
continued to subculture in 50 ml freshly prepared autoclaved medium twice before 
further analysis. 
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Table 2.3 Optimum temperature and medium required for cultivation of predominant 
groups of intestinal bacteria (Oxoid catalogue, Hampshire, UK) 
Bacterial species Cultivation Cultivation medium 
(JCM number) temperature 
Lactobacillus brevis (1059) 30°C de Man-Rogosa-Sharpe medium 
Bifidobacterium longum (1217) 37°C Reinforced clostridial medium 
Clostridium celatum (1394) 37°C Reinforced clostridial medium 
2.6.3 Validation of oligonucleotide probes for FISH 
Bacterial pure culture suspended in medium (375 |_il) was diluted 1:3 (v/v) with 
filtered 4% (w/v) paraformaldehyde in PBS, which contained (gl]) NaHsPCVSEbO， 
4.933; Na2HP04, 9.704; paraformaldehyde, 40 at pH 7.2 and stored at 4°C overnight. 
The fixed cells were centrifuged at 10,000 g for 10 minutes, washed with 1 ml of 0.1 
M PBS at pH 7.0 twice and resuspensed in 300 i^l 100% methanol. The sample was 
mixed and stored at -20°C for at least 1 hour but no more than 3 months until further 
processing. For the hybridisation of Lactobacilli, the methanol suspended bacterial 
cells (300 ^1) were washed with 1 ml of 0.1 M PBS at pH 7.0 twice and mixed with 
145 |il of freshly prepared lysozyme from chicken egg white (2 mgmr^) and lipase 
from porcine pancreas (0.1 mgrnl"^) in a mixture of buffer (25 mM Tris-HCl pH 7.5, 
10 mM EDTA, 585 mM sucrose, 5 mM CaCb and 0.3 mgrnl"^ sodium taurocholate) 
at 37°C for 1.5 hours. The mixture was further mixed with 10 of protease K (0.2 
ligml"^) at 37°C for 10 minutes. The mixture was further incubated with 465|il of 4% 
paraformaldehyde in PBS at pH 7.2 (v/v) at 4。C for 10 minutes. The cells were 
further washed with 1 ml of 0.1 M PBS at pH 7.0 twice and resuspended in 300 of 
100% methanol at -20。C for at least 1 hour but no more than 3 months until further 
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processing. 
The methanol-fixed cells (10 [il) were added to prewarmed 70 |il of autoclaved 
ultra-pure water and 200 i^l of filtered double strength hybridisation buffer (1.8 M 
NaCl, 40 M Tris-HCl, pH 7.2, 0.2% sodium dodecyl sulphate) and mixed. The 
mixture was mixed with individual oligonucleotide probes (50 ngjil]) at a ratio of 
9:1 (v/v) and incubated at appropriate hybridisation temperature (Bif 164 and His 
150 at 50。C; Bac 303 and Lab 158 at 45°C) for 16 hours. 
The hybridised sample (2-50 ^il) was washed in 5 ml of prewarmed and mixed with 
filtered single strength hybridisation buffer (0.9 M NaCl, 20 M Tris-HCl, pH 7.2) 
containing 20 [i\ of DAPI solution (500 ng|j,r )^ for 30 minutes at the appropriate 
hybridisation temperature of the respective probe. Bacterial cells were vacuum 
filtered onto a 0.22 |im pore size filter (Millipore, County Cork, Ireland) and 
mounted with SlowFade® Gold antifade reagent (Molecular probe, Leiden, the 
Netherlands) on a microscope slide and covered with a cover slip with seal. The 
filters were viewed at xlOOO magnification with a fluorescent microscope (Leica, 
Wetzlar, Germany) equipped with an oil lens and appropriate optical blocks: UV-2A, 
G-2A and B-2A (Nikon, Tokyo, Japan) for DAPI stain (excited at 359 nm and 
emitted at 461 nm), Cy3 (excited at 550 nm and emitted at 565 nm) and FITC 
(excited at 488 nm and emitted at 543 nm) dye, respectively (figure 2.3a-c). 
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Figure 2.3 Combinations of excitation and emission filters in optical block of 
fluorescent microscope 
(a) Purple excitation filter combination in Nikon UV-2A optical block for DAPI 
(b) Green excitation filter combination in Nikon G-2A optical block for Cy3 
(c) Blue excitation filter combination in Nikon B-2A optical block for FITC 
(Adapted from http://www.microscopyu.com) 
40 
2.7 Bacterial enumeration of fermentation broth by FISH 
2.7.1 Automated image analysis 
Fecal bacterial samples obtained from static batch culture fermentations (section 2.2), 
growth curve analysis (section 2.4) and three-stage continuous fermentations (section 
2.5) were enumerated through the same procedure described in 2.6.3. A minimum of 
15 microscopic fields in each slide containing 10-100 cells was counted manually for 
batch culture fermentations (section 2.2). A minimum of 15 microscopic fields in 
each slide containing 10-100 cells was randomly captured by a FDX-35 digital 
camera (Nikon, Tokyo, Japan) and saved as 1280 x 1024 pixels format for growth 
curve analysis and three-stage continuous fermentation (section 2.4 and 2.5) and 
further analysed by an automated image analysis software (CellC) as described 
below. 
Fluorescent microscopic bacterial cells images captured from the digital camera were 
quantified with automated image analysis software, CellC. The software was freely 
available at www.cs.tut.fi/sgn/csb/cellc. This software was capable of analyzing the 
total cell image (DAPI stained) and specific cell image (Cy3 or FITC stained), 
captured from the same field at the same time (figure 2.4). After loading the total cell 
image into the software, the intensity threshold was adjusted manually in case of 
strong auto-fluorescence background or in low contrast images. The automatic 
background correction was set on to correct for brightness variations in background 
due to background auto-fluorescence and uneven illuminations. Changes in threshold 
setting can be observed readily from the graphical threshold adjuster. To enable data 
acquisition on a cell-by-cell basis, the parameter to divide cells into single cells was 
set to 0.9. The artifacts were removed automatically by discarding objects smaller 
than 20 pixels or greater than 9999 pixels in the captured image. The total cell count 
as well as a binarized image with white cells on a black background were 
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automatically produced after analysis. The analysis procedure was repeated with the 
specific cell image, in which only objects that are visible in both images are regarded 
as specific cell count. 
Total cell image (DAPI stained) Specific cell image (Cy3 stained) 
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Figure 2.4 Layout of CellC software for total and specific cell enumeration and 
operational settings 
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2.7.2 Quantification of bacteria 
The number of bacteria per millilitre was calculated by using a conversion factor 
derived from the number of fields in the filtered area and the volume of cells filtered. 
The Conversion Factor (CF) is the number of microscopic fields that can be observed 
in the filter. The CF for manual and automated enumeration was calculated as below: 
Areapiiter 
CF = ⑷ 
Areapieid 
in which Areapiiter is the area of the filter (mm^) and equals to tc x 6.5^; Areapieid is the 
area of the microscopic field (mm】) and equals to tt x 0.105^ for manual enumeration 
and 0.09 x 0.07 for automated enumeration. 
CF xMcountX VMethanol X Voouble strength xVprobe 
Bacterialcount (g])= ( ” 
VcellX Vcell 1X Ycel 丨 2 X Vcell3 xFo/o 
in which CF is the Conversion Factor for manual or automatic enumeration 
calculated above; Mcount is the number of cells that can be observed under the 
microscope or from the captured image; VMethanoi is the volume of methanol that the 
bacterial cells are suspended in and is equalled to 300 fil; Vooubie strength is the total 
volume of methanol suspended cells, double strength buffer solution and ultra-pure 
water mixture and is equalled to 280 |j.l; Vprobe is the total volume of diluted cells and 
DNA probe for hybridisation and is equalled to 50 |j.l; Vceii is the volume of cells 
removed from the fermentation system and is equalled to 0.375 ml; Vceiii is the 
volume of methanol fixed cells used for assay (fil); Vceii2 is the volume of diluted 
cells mixed with DNA probe and is equalled to 45 Vceiis is the volume of 
hybridised sample washed in single strength buffer solution F。/。is the percentage 
of fecal sample in the fermentation inoculum. 
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2.8 Gas chromatographic determination of short-chain fatty acids (SCFAs) 
Fermentation broth sampled from the static batch culture in section 2.2 and 
three-stage continuous fermentations in section 2.5 were mixed with 10 M copper (11) 
sulphate (20 i^l) and kept at -20°C until SCFA analysis. The frozen samples 
containing non-fermented residue was thawed and centrifuged in the Beckman 
GS-15R centrifuge with F-2402 rotor at 4,800 rpm (2061 xg) for 30 minutes at 4°C. 
The supernatant (0.35 ml) was then transferred into a new eppendorf tube and was 
acidified by adding 83 of 25% meta-phosphoric acid and 62.5 |il (4 mgmr^) 
4-methyl-pentanoic acid (catalog no. 6220601, Alltech, Kentucky, USA) as internal 
standard. The mixture was incubated at room temperature for 30 minutes and 
vortex-mixed with 0.5 ml of diethyl ether. It was allowed to stand for 10 minutes for 
phase separation. The top layer (diethyl ether with dissolved SCFAs) was 
quantitatively transferred into another eppendorf and the bottom layer (containing 
remaining SCFAs) was further extracted twice with 0.5 ml of diethyl ether. The 
diethyl ether extracts containing SCFAs were pooled together followed by 
dehydration with anhydrous sodium sulfate and filled into sample vials via 0.45 |im 
mixed cellulose esters membrane filter (catalogue no. HAWG04700, Millipore, 
Ireland). Extracted SCFAs in diethyl ether (10 i^l) were injected into a gas 
chromatography system (Hewlett packard HP6890 series, USA). A fused silica 
capillary column Quadrex 007-FFAP (Alltech, Deerfield, Ireland) (30 m x 0.25 mm 
inner diameter, 0.25 }am film) was used and the initial temperature of the oven was 
set at 100。C with a hold of 5 minutes, followed by a temperature rise of 3。C per 
minute to a final temperature of 160°C with a final hold for 5 minutes. The 
temperature of both injector and the flame ionization detector was set at 220。C‘ 
Helium was used as carrier gas with a constant flow rate of 1,5 ml per minute. Acetic 
acid, propionic acid, butyric acid, pentanoic acid, hexanoic acid, heptanoic acid and 
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octanoic acid from a SCFA standards kit (catalog no. 186000，Alltech, Kentucky, 
USA) were mixed with 4-methyl-pentanoic acid as internal standard at a final 
concentration of 0.5 mgrnl'^ for detection and quantification. The amount of SCFAs 
produced from the sugar alcohols and FOS at 0 and after 24 hours (and after 48 hours 
in continuous fermentation) of in vitro fermentation was expressed as millimoles per 
kilogram of fecal wet weight. 
The Response Factors (R F s c f a) for each SCFAs was calculated as below: 
Peakintemal standard X WcightsCFA 
R F s c f a = 
P e a k s C F A X W e i g h t i n t e m a l standard 
in which Peakintemal standard is the GC peak area of internal standard; WeightscFA is the 
weight of individual SCFAs standard used in the assay (mg); PeakscFA is the GC 
peak area of individual SCFAs standard; W e i g h t i n t e m a l standard is the weight of internal 
standard used in the assay (mg). 
The content (mmolkg"^ of fecal wet weight) of individual SCFAs produced during in 
vitro fermentation was calculated as follow: 
R F s c f a xPeakscFA x W i s x Sjotai x 1 0 0 0 ( 7 ) 
Individual SCFA (mmolkg V 
Peakis X SAssay X FRAssay X M M X F。/。 
in which R F s c f a is the Response Factor of individual SCFAs calculated above; 
PeakscFA is the GC peak area for individual SCFAs in sample solution; Wis is the 
weight of internal standard used in the sample solution; STotai is the total volume of 
supernatant from the removed fermented residue; Peakis is the GC peak of internal 
standard in sample solution; SAssay is the aliquot of supernatant for assay and is 
equalled to 0.35 ml; FRAssay is the aliquot of fermented residue for assay and is 
equalled to 1 ml; M M is the molar mass (gmol"') of individual SCFA (acetic acid, 
45 
60.05; propionic acid, 74.08; butanoic acid, 88.11); F% is the percentage of fecal 
sample in fermentation broth. 
2.9 Statistical analysis 
The DMD and OMD percentages were analyzed using one-way ANOVA and Tukey's 
multiple comparison test to determine the significant difference between mean values 
of the four sugar alcohols and the positive control (FOS) at p<0.05. 
Differences between bacterial counts and SCFA concentrations at 0 and after 24 
hours batch culture fermentation for each substrate were tested for significance using 
student's t-tests assuming equal variances and considering both sides of the 
distribution (2-tailed) atp<0.05. 
The percentage increase after 48 hours three-stage continuous fermentation in 
different bacterial counts and SCFA concentrations in vessels 1 to 3 were analyzed 
using one-way ANOVA and Tukey's multiple comparison test to determine the 
significant difference between mean values in the same vessel fed with either only 
fermentation culture medium or 1% FOS/ lactitol (w/v) in fermentation culture 
medium atp<0.05. 
The total and individual SCFA concentrations in vessels 1 to 3 were analyzed using 
one-way ANOVA and Tukey's multiple comparison test to determine the significant 
difference between mean values at different time intervals (at 0 and after 24 and 48 
hours) in the same vessel fed with either only fermentation culture medium or 1% 
FOS/ lactitol (w/v) in fermentation culture medium atp<0.05. 
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Chapter 3. Results and Discussion 
3.1 Dry matter and organic matter disappearance in batch culture 
fermentations 
The dry matter disappearance (DMD) and organic matter disappearance (OMD) 
percentages of all tested substrates after 24-hour in vitro fermentation using human 
fecal microflora are presented in table 3.1. FOS was served as the positive control in 
this study since its utilization by the selective colonic bacteria has been demonstrated 
in numerous studies (Probert and Gibson, 2002; Kaplan and Hutkins; 2000, Marx et 
al., 2000; Gibson and Wang, 1994a). After 24-hour in vitro fermentation by human 
colonic bacteria, sorbitol, mannitol and lactitol had similar DMDs (97.41%, 87.31% 
and 87.97%, respectively) and OMDs (89.25%, 89.27% and 87.22%, respectively) 
when compared with those of the positive control (DMD, 94.91%; OMD, 87.13%). 
This suggested that sorbitol, mannitol and lactitol which escape the digestion and 
absorption in the upper gastrointestinal tract of humans could be fermented as 
effective as FOS by the endogenous bacteria to give metabolites such as short-chain 
fatty acids and gases in the colon. Among all sugar alcohols tested, xylitol was the 
least fermented (/?<0.05), having a significantly lower DMD (57.01%) and OMD 
(52.81%) than the positive control. The values of DMD and OMD for cellulose, 
which has been used in a previous similar in vitro study as the negative control 
because of its limited degradation by the human colonic bacteria, were 3.34% and 
3.84%, respectively (Wong et al., 2005). By comparison, xylitol reaching the human 
colon is less fermentable than fructo-oligosaccharides but much more fermentable 
than cellulose by the colonic bacteria. 
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Table 3.1 DMD and OMD of in vitro fermentation of different substrates at 0 and 24 
hour using human fecal microflora^ 
Dry matter disappearance Organic matter disappearance 
(DMD) (%) (OMD) (%) 
FOS* 94.91±10.76%a 87.13±3.88%^ 
Xylitol 57.01±9.27o/ob 52.81±12.32%'' 
Sorbitol 97.41±15.00%a 89.25±5.42%' 
Mannitol 87.31±4.84%" 89.27±1.71%' 
Lactitol 87.97±3.20%a 87.22±0.58%" 
*FOS: Fructo-oligosaccharides 
"Data are the mean values 土 S.D (N=3) 
Different letters in the superscripts within the same column indicated significant 
difference among fermentation substrates (/?<0.05, one-way ANOVA, Tukey's 
multiple comparison test) 
3.2 Validation of genus-specific oligonucleotide probes for FISH by pure 
bacterial culture 
Figures 3.1, 3.2 and 3.3 show the images of pure human intestinal bacterial culture 
including Bifidobacterium longum, Clostridium ce latum and Lactobacillus brevi, 
respectively. The bacteria were both stained with DAPI and hybridised with Cy3 
linked genus-specific oligonucleotide probes for fluorescent in situ hybridisation 
(FISH) oligonucleotide probes validation. 
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Figure 3.1 Image of (a) Bifidobacterium longum pure bacterial culture labelled with 
Bif 164 oligonucleotide probes (Cy3) targeting the bifidobacteria! genus captured 
under Nikon G-2A optical block; (b) total bacteria stained by DAPI captured under 
Nikon UV-2 A optical block 
Figure 3.2 Image of (a) Clostridium celatum pure bacterial culture labelled with His 
150 oligonucleotide probes (Cy3) targeting the Clostridium perfiingens/ histolyticum 
subgroup captured under Nikon G-2A optical block; (b) total bacteria stained by 
DAPI captured under Nikon UV-2 A optical block 
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Figure 3.3 Image of (a) Lactobacillus brevis pure bacterial culture labelled with Lab 
158 oligonucleotide probes (Cy3) targeting the Lactobacilli/ Enterococci group 
captured under Nikon G-2A optical block; (b) total bacteria stained by DAPI 
captured under Nikon UV-2A optical block 
3.3 FISH and multi-color FISH of human fecal bacteria 
Figures 3.4a-c show the results of multi-color FISH using human fecal samples. 
When multi-color FISH (hybridised with oligonucleotide probes targeting 
Bifidobacteria (Cy3) and Clostridium perfringem/ histolyticum subgroup (FITC) 
together) was applied to the human fecal samples under the same hybridisation 
temperature (50°C), different bacterial genera could be identified clearly in the 
bacterial cultures by the different colors for each genus i.e. red and green for 
Bifidobacteria and Clostridium perjringens/ histolyticum subgroup, respectively. 
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Figure 3.4 Image of (a) human fecal bacteria labelled with Bif 164 oligonucleotide 
probes (Cy3) targeting bifidobacteria! genus captured under Nikon G-2A optical 
block; (b) human fecal bacteria labelled with His 150 oligonucleotide probes (FITC) 
targeting the Clostridium perfringens/ histolyticum subgroup captured under Nikon 
B-2A optical block; (c) total human fecal bacteria stained by DAPI captured under 
Nikon UV-2A optical block 
Although the oligonucleotide probes targeting Bacteroides and Lactobacilli had the 
same hybridisation temperature at 45°C, individual genus of Bacteroides and 
Lactobacilli in the human fecal samples might not be identified by their color when 
using the multi-color FISH. This was because it is difficult for the probes to penetrate 
the Gram-positive bacterial cell wall like Lactobacilli due to the irreversible 
cross-linking of the cell wall components during paraformaldehyde fixation. 
Therefore, an enzymatic pre-treatment with glycosidase (lysozyme) and lipase 
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(pancreatic lipase) of the bacterial cells is needed before the hybridisation (Roller et 
al, 1994; Beimfohr et al., 1993). However, during the enzymatic pre-treatment 
process of fecal sample before hybridisation, Gram-negative bacteria like 
Bacteroides in the sample were very sensitive to the lysozyme treatment and lysed 
during incubation, resulted in a negative result on the subsequent multi-color 
hybridisation steps (Harmsen et al., 1999). Therefore, separate FISH procedures are 
used to identify Lactobacilli and Bacteroides (figures 3.5 and 3.6 show the results for 
FISH using human fecal samples incubated with Cy3 linked Bac 303 and Lab 158 
oligonucleotides probes targeting Bacteroides and LactobacWi, respectively) as 
multi-color FISH is not effective for spotting Lactobacilli and Bacteroides in the 
human fecal samples simultaneously. 
Figure 3.5 Image of (a) human fecal bacteria labelled with Bac 303 oligonucleotide 
probes (Cy3) targeting Bacteroides genus captured under Nikon G-2A optical block; 
(b) total human fecal bacteria stained by DAPI captured under Nikon UV-2A optical 
block 
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Figure 3.6 Image of (a) human fecal bacteria labelled with Lab 158 oligonucleotide 
probes (Cy3) targeting Lactobacilli genus captured under Nikon G-2A optical block; 
(b) total human fecal bacteria stained by DAPI captured under Nikon UV-2A optical 
block 
3.4 Enumeration of fecal bacteria with the CellC software 
To enumerate the bacteria in the fermentation system, captured fluorescent 
microscopic images were loaded into the CellC software. After analysis, binarized 
images with white cells on dark background for the total as well as the specifically 
stained bacteria in the sample can be automatically produced. Figure 3.7b shows the 
result for the enumeration of the total fecal bacteria and figure 3.7d shows the result 
for the enumeration of the specific stained bacteria with the CellC software, in which 
only objects that are visible in both images are regarded as specific cell count. 
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Figure 3.7 Image of (a) total human fecal bacteria stained with DAPI captured under 
Nikon UV-2A optical block; (b) CellC software analyzed binarized figure and the 
number of total cell counts; (c) human fecal bacteria labelled with Bac 303 
oligonucleotide probes (Cy3) targeting Bacteroides genus captured under Nikon 
G-2A optical block; (d) CellC software analyzed binarized figure and the number of 
specific stained Bacteroides counts 
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3.5 Colonic bacterial profile in batch in vitro fermentation 
3.5.1 Total colonic bacteria 
FOS (the positive control) and lactitol had the strongest stimulatory effect on the 
total colonic bacterial growth, with a 36.75% and 25.36% significant increase 
(p<0.05) after 24 hours of in vitro fermentation, respectively (figure 3.8). 
Dietary FOS and lactitol would not be digested in humans until they reach the colon 
for bacterial fermentation because of the lack of (3-fructosidases and P-galactosidases 
in humans, respectively to digest them (Gibson et al., 2004; Olinger and Pepper, 
2001). The increase in total bacterial counts by FOS and lactitol after 24-hour in vitro 
fermentation indicated that there were particular dominant groups of colonic bacteria, 
which could utilize FOS and lactitol effectively as the growth substrate. This was 
because these substrates could be broken down into fructose and glucose as well as 
sorbitol and galactose, respectively by the bacterial secreting or associating enzymes 
(Franck, 2002; Wang and van Eys, 1981). Xylitol, sorbitol and mannitol did not show 
significant changes (^>0.05) in the total bacterial populations. This suggested that 
there was no significant stimulation of the predominant groups of the colonic bacteria 
populations by these sugar alcohols used as growth substrates (figure 3.8). As 
mentioned in section 1.11，the fermentation of sugar alcohols by the colonic bacteria 
is initiated by the phosphoenolpyruvate-dependent phosphotransferase system (PTS) 
to form polyol-phosphate, which eventually enters the hexose or pentose catabolic 
pathway for metabolism (Yebra and Martinez, 2002; London and Chace, 1977). After 
the phosphorylation of mannitol and sorbitol, the bacterial polyol dehydrogenases 
can convert both mannitol-6-phosphate and sorbitol-6-phosphate to 
fructose-6-phosphate, which can be further converted into pyruvate (Vries and 
Stouthamer, 1986). Therefore bacteria possessing polyol dehydrogenases are capable 
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Figure 3.8 Total colonic bacterial populations of in vitro fermentation of sugar 
alcohols and FOS at 0 and 24 hour using human fecal microflora. Data are the mean 
value of microscopic count (g feces) 土 S.D. (N=3) with PBS as the cultivation 
medium at 37°C anaerobic condition. 
* indicates significant difference using student's t-tests assuming equal variances and 
considering both sides of the distribution (2-tailed) in the number of bacteria between 
0 and 24 hours of fermentation (/?<0.05) 
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3.5.2 Bacteroides 
Bacieroides is one of the five predominant genera found in the human colon and is 
commonly regarded as a health-neutral bacterial genus (Salyers, 1984). Changes in 
Bacteroides population were not significant after 24 hours in vitro fermentation of 
the different substrates except xylitol. Xylitol had shown a marked decrease (44.67%) 
(p<0.05) in Bacteroides population after 24 hours in vitro fermentation (figure 3.9). 
The changes of the bacterial counts depend on the comparative suitability of the 
bacteria to utilize the substrate for metabolism to sustain their growth. From the dry/ 
organic matter disappearance analysis (Table 3.1)，xylitol showed the lowest 
disappearance percentages among the tested substrates. Such comparatively lower 
fermentability found in xylitol might be due to the inability of a large number of 
bacteria to utilize pentitol as the growth substrate (London and Chace, 1977). 
Although the mechanism of the inhibitory effect of xylitol on each colonic bacterial 
species is unclear, the inhibition effect of xylitol on the Streptococcus and lactic acid 
bacteria have been reported previously (Soderling and Pihlanto-Leppala, 1989; 
Trahan et al, 1985). The antimicrobial effect of xylitol on Streptococcus is based on 
its transport and phosphorylation through a fructose phosphotransferase system 
(PTS), which is possibly due to its structural similarity to the fructose molecules 
(Trahan et al., 1985). Unlike mammalian cells, Streptococcus and most of the lactic 
acid bacteria cannot metabolize xylitol phosphate any further, which resulted in an 
energy-consuming process of xylitol expulsion and intracellular accumulation of 
xylitol phosphate, leading to the bacterial growth inhibition (Soderling and 
Pihlanto-Leppala, 1989). Therefore, only certain bacterial species such as 
Lactobacilli casei strain CI-83, which possess a specific xylitol phosphotransferase 
system, can utilize xylitol as growth substrate and would not lead to a growth 
reduction (London and Chace, 1977). 
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In a previous study, six glycosidases, namely a/p-glucosidases, a/p-galactosidases, 
P-N-acetyl glucosamididases and a-L-flicosidases were identified from Bacteroides 
fragilis, one of the major species found in human colon (Berg et al., 1980). 
Bacteroides pure culture could not grow on fructo-oligosaccharides because of the 
inability of Bacteroides to secrete p-fructosidases to breakdown 
fructo-oligosaccharides into fructose and glucose molecules for metabolism (Gibson 
and Wang, 1994a). However, in a heterogeneous environment such as human fecal 
slurry, Bacteroides do not have a significant lethal effect on 
fructo-oligosaccharides-riched medium, though with an insignificant growth rate 
(p>0.05) (figure 3.9)，because some bacteria such as Bifidobacteria are able to 
secrete P-fructosidases to digest fructo-oligosaccharides into monosaccharides or 
disaccharides, in which some of them would be utilized by other bacteria such as 
Bacteroides for metabolism. 
Bacteroides contains P-galactosidases for lactitol digestion, but lactitol still could not 
boost a significant growth in Bacteroides population (/?>0.05) (table 3.2). Since 
lactitol stimulates a significant increase in bifidobacteria! population (/?<0.05) (figure 
3.10), in which their metabolites mainly lactic acid and acetic acid would have a 
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Figure 3.9 Bacteroides/ Prevotella populations of in vitro fermentation of sugar 
alcohols and FOS at 0 and 24 hour using human fecal microflora. Data are the mean 
value of microscopic count (g feces) 土 S.D. (N=3) 
* indicates significant difference using student's t-tests assuming equal variances and 
considering both sides of the distribution (2-tailed) in the number of bacteria between 
0 and 24 hours of fermentation (/?<0.05) 
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3.5.3 Bifidobacteria 
The increase of the bifidobacteria! population is always one of the targets for 
determining the prebiotic effect of potential substrates since the activity of 
Bifidobacteria is closely associated with the host's health (Gibson and Roberfroid, 
1995). Two hypotheses have been proposed to explain the beneficial health effects of 
increasing bifidobacteria! populations in human colon. Firstly, increase in 
bifidobacteria! population can prevent intestinal colonization by pathogens in terms 
of competing for nutrients, space and binding sites on the epithelial surface 
(Okamura et al” 1986). Secondly, during carbohydrates fermentation by 
Bifidobacteria, lactic acid and acetic acid production would result in an intestinal pH 
reduction and consequently inhibit the growth of the undesirable harmful bacteria 
such as Clostridia (Rasic, 1983). 
The bifidobacteria! count in the in vitro system having different substrates varied 
after 24 hours of fermentation (figure 3.10). Lactitol had a bifidogenic effect that 
significantly (/?<0.05) increased the bifidobacteria! counts by 91.71%, after 24 hours 
of fermentation. In a previous study, fermentation of lactitol had a lethal effect on 
Bifidobacteria and decreased total bacterial cell numbers (Probert et a/., 2004). In 
other studies, lactitol was concluded to be a bifidogenic factor but with a less marked 
effect than FOS (Mitsuoka et al, 1987). Lactitol had also been shown to stimulate 
the growth of different Bifidobacteria pure culture species strongly by about 
100-300% in 24 hours (Ballongue et al., 1997). In this study, lactitol demonstrated a 
significant stimulation of Bifidobacteria. This could be explained by the ability of 
Bifidobacteria to produce (3-galactosidases, which has a broad substrate-specificity, 
to hydrolyse substrates such as lactitol (Salminen et al., 1998) as well as the 
hydrolysed products of lactitol especially galactose as one of the preferred 
fermentable sugars by Bifidobacteria (Mitsuoka, 1984). 
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FOS consistently showed a significant selective stimulation on bifidobacteria! counts 
(p<0.05) (figure 3.10) after 24 hours in vitro fermentation as shown in other similar 
studies (Probert and Gibson, 2002; Kaplan and Hutkins; 2000, Marx et al, 2000; 
Gibson and Wang, 1994a). Such specific bifidobacteria! population stimulation is due 
to the fact that Bifidobacteria are able to secrete P-fructosidases for FOS digestion 
and Bifidobacterium species have a greater preference for fructans than glucose as 
substrate (Hopins et al., 1998; Gibson and Wang, 1994a). During in vitro 
fermentation of FOS by Bifidohacterium spp., the pH of the culture would drop 
obviously (with pH 2.8 differences) due to lactic and acetic acid production (Gibson 
and Wang, 1994c). This on one hand inhibits the growth of the undesirable bacteria, 
on the other hand provides a more favourable acidic condition for the growth of 
Bifidobacteria (Rasic, 1983). 
Sorbitol and mannitol did not promote any significant bifidobacteria! growth after 24 
hours of fermentation (figure 3.10), because only some of the bifidobacteria! species 
such as Bifidohacterium catenumatum and Bifidobacterium dentium are able to 
ferment sorbitol and mannitol, respectively (Mitsuoka, 1984). Xylitol even inhibited 
the growth of colonic Bifidobacteria (figure 3.10), which might also be due to the 
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Figure 3.10 Bifidobacteria populations of in vitro fermentation of sugar alcohols and 
FOS at 0 and 24 hour using human fecal microflora. Data are the mean value of 
microscopic count (g feces)土 S.D. (N=3) 
* indicates significant difference using student's t-tests assuming equal variances and 
considering both sides of the distribution (2-tailed) in the number of bacteria between 
0 and 24 hours of fermentation (/?<0.05) 
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3.5.4 Clostridia 
Clostridium is regarded as a health-deteriorating bacterial genus, which may cause an 
accumulation of the potentially toxic and carcinogenic end products such as 
ammonia, phenolic compounds and amines during its proteolytic fermentation 
(Cummings and Macfarlane, 1991). Several Clostridium species such as Clostridwm 
difficile are associated with different kinds of gastrointestinal diseases as well 
(Gerding et al., 1988). Because of the pathogenic property of Clostridia, reduction of 
clostridial population is one of the targets for prebiotics (Gibson and Roberfroid, 
1995). Both xylitol and FOS showed the strongest inhibition (/?<0.05) on the growth 
of Clostridium during the 24-hour in vitro fermentation, with a 40.50% and 38.96% 
significant decrease, respectively (figure 3.11). Sorbitol, mannitol and lactitol also 
demonstrated significant inhibitory effects (p<0.05) on the growth of clostridial 
populations, with 15.77%, 25.10% and 28.15% reduction, respectively (figure 3.11). 
The drastic reduction in clostridial population found in FOS and the tested sugar 
alcohols in this study might be due to several factors. Although a majority of the 
Clostridia were saccharolytic, some clostridial species such as Clotsridium 
malenominatum were asaccharolytic (Hopkins and Macfarlane, 2002). Increased in 
carbohydrates sources during in vitro fermentation study would thus inhibit the 
growth of the asaccharolytic species. Other studies showed that the increased in 
short-chain fatty acid concentration, particularly butyrate would result in a growth 
inhibition in Clostridium species (Gibson and Wang, 1994b; May et al., 1994). The 
production of antimicrobial components from lactic acid bacteria as well as intensive 
nutrients and space competitions under the in vitro fermentation conditions in the 
present study might also inhibit the growth of Clostridia (Gibson and Wang, 1994c). 
63 
3 
2.5 内 r-1 由 ， 丄 
r ^ 氺 * * 
到 _11|1|1|11| 
Ohr 24hr Ohr 24hr Ohr 24hr Ohr 24hr Ohr 24hr 
) FOS Xylitol Sorbitol Mannitol Lactitol 
Figure 3.11 Clostridium perfringem/ histolyticum subgroup populations of in vitro 
fermentation of sugar alcohols and FOS at 0 and 24 hour using human fecal 
microflora. Data are the mean value of microscopic count (g feces) 土 S.D. (N=3) 
* indicates significant difference using student's t-tests assuming equal variances and 
considering both sides of the distribution (2-tailed) in the number of bacteria between 
0 and 24 hours of fermentation (/?<0.05) 
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3.5.5 Lactobacilli 
Lactobacilli are regarded as health-promoting bacteria by producing a range of 
antimicrobial agents such as organic acids and bacteriocins. However, they are 
present in a relatively low amount in the human colon at about 0.01% of total 
bacterial count (Aries, 1969). In this study, changes in Lactobacilli counts before and 
after 24-hour in vitro fermentation were not significant in all tested substrates except 
xylitol, in which a significant growth inhibition (^<0.05) was observed (figure 3.12). 
In fact, Lactobacilli are the best producer of a-glucosidases and a/p-galactosidases 
(Hill, 1995). It has been showed in a placebo-controlled double-blinded crossover 
study in humans that lactitol could increase the number of Lactobacilli in the human 
intestinal tract by the action of P-galactosidases to digest lactitol into galactose and 
sorbitol (Ballongue et al., 1997). However, the insignificant increase of Lactobacilli 
population by lactitol in this study may be due to the intense competitions with other 
dominant bacterial genera such as Bifidobacteria in the present closed fermentation 
system. 
Also, in a previous selective in vitro fermentation culture study, Lactobacilli was 
shown to prefer fructo-oligosaccharides in a lesser extent than Bifidobacterium to 
sucrose (Gibson and Wang, 1994a). Besides, only 75% of the Lactobacilli species 
when compared with 87.5% of the Bifidobacteria species were able to grow on agar 
containing fructo-oligosaccharides in an in vitro study (Kaplan and Hutkins, 2000). 
Therefore, the combination of the above factors may result in the failure of 
Lactobacilli to compete with the predominant genus Bifidobacteria for nutrients 
(fructo-oligosaccharides) in the closed environment and consequently lead to the 
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Figure 3.12 Lactobacilli/Enterococci group populations of in vitro fermentation of 
sugar alcohols and FOS at 0 and 24 hour using human fecal microflora. Data are the 
mean value of microscopic count (g feces)土 S.D. (N=3) 
* indicates significant difference using student's t-tests assuming equal variances and 
considering both sides of the distribution (2-tailed) in the number of bacteria between 
0 and 24 hours of fermentation (/?<0.05) 
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3.6 Short-chain fatty acids (SCFAs) in batch in vitro fermentation 
3.6.1 Total SCFA concentration 
Short-chain fatty acids (SCFAs) including mainly acetate, propionate and butyrate 
are the principal end products during colonic bacterial fermentation (Cummings et al., 
1987). When there is plentiful of nutrients supply, colonic bacteria would have a 
faster growth rate and result in a higher rate of short-chain fatty acid production, 
causing a marked reduction in the colonic pH (Macfarlane and Gibson, 1994) (Figure 
3.13) 
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Figure 3.13 Correlation between pH at 0 and 24 hours of in vitro fermentation with 
different substrates and the concentration of total SCFAs production 
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During the 24-hour in vitro fermentation, lactitol produced the highest concentration 
of total short-chain fatty acids followed by FOS, sorbitol, mannitol and xylitol (figure 
3.13). The lowest level of short-chain fatty acid production by xylitol could be 
explained by its low fermentability as shown in the DMD and OMD values in table 
3.1. Xylitol was the least fermentable substrates by the human colonic bacteria, thus 
the production of the fermentation end-products (short-chain fatty acids) as well as 
the reduction of the pH would be less than the other more fermentable substrates in 
this study. In general, the results of total short-chain fatty acid production of other 
sugar alcohols (figure 3.13) were consistent with those of fermentability in terms of 
DMD and OMD (table 3.1). 
3.6.2 Acetate 
The acetate production of the four sugar alcohols and FOS at 0 and after 24 hours of 
in vitro fermentation using human fecal microflora is shown in figure 3.14. Acetate is 
the major product in colonic fermentation because the dominant bacterial genera in 
the colon such as Bacteroides and Bifidobacteria are the acetate producers, in which 
one-third of acetate are formed by the carbon dioxide reduction (Macfarlane and 
Macfarlane, 2003; Miller and Wolin, 1996). All tested substrates had shown a 
significant (^<0.05) increase in the acetate concentration after 24 hours in vitro 
fermentation except xylitol (figure 3.14). The insignificant change of acetate 
concentration in xylitol fermentation might due to the fact that certain colonic 
bacteria in the fecal inoculum, as demonstrated in figures 3.9-12, could not utilize 
pentitol as metabolic substrate and hence affect acetate production greatly in xylitol 
fermentation (London and Chace, 1977). 
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3.6.3 Propionate 
During the 24-hour in vitro fermentation, all tested substrates had a significant 
increase in propionate concentration (figure 3.14). The increase of propionate 
production in all the tested substrates might imply that there was a significant 
increase of propionate producers like Propionibacteria in the bacterial population by 
the carbon dioxide fixation pathways (Miller and Wolin, 1996). Also, during the 
24-hour in vitro fermentation of different sugar alcohols, the predominant colonic 
genus Bacteroides had a relatively slower growth rates (figure 3.9). It is suggested by 
Kotarski and Salyers (1981), the main products of carbohydrate fermentation by 
Bacteroides are acetate and succinate at normal growth rate, while Bacteroides 
increases its propionate production and decreases its succinate production when 
having a relatively slower growth rate. Therefore, Bacteroides may contribute to the 
significant increase in propionate during the in vitro fermentation. 
3.6.4 Butyrate 
Similar to propionate, all tested substrates also had a significant increase (^<0.05) in 
butyrate concentration (figure 3.14). Although most of the predominant colonic 
bacteria such as Bifidobacteria and Bacteroides are not butyrate producers, butyrate 
production is still significant in the human fecal slurry because of the significant 
conversion of lactate to butyrate by the lactate-utilizing bacteria (Bourriaud et al., 
2005; Duncan et al, 2004; Bourriaud et al., 2002). Lactate is seldom detected as the 
principal short-chain fatty acid produced during colonic fermentation even with a 
marked proportion of lactate producers such as Bifidobacteria. This is because 
Eubacterium hallii, which accounts for 2 to 3% of the human fecal community as 
well as Megasphaera, Veillonella and Anaerostipes are capable of converting lactate 
into butyrate in the human colonic system (Harmsen et al., 2002; Schwiertz et al., 
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2002). These might explain the present results that a significant increase in the 
butyrate production after 24 hours in vitro fermentation of the tested substrates. 
Among the short-chain fatty acids, butyrate is the most interesting one because it is 
an important energy source for the colonocytes and it controls colonic cell growth 
and differentiation (Cummings, 1995). An increased butyrate concentration during 
human colonic fermentation with different tested substrates may provide further 
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Figure 3.14 Short-chain fatty acid profile of in vitro fermentation of sugar alcohols 
and FOS at 0 and 24 hours using human fecal microflora. Data are the mean value of 
per wet weight of feces (mmolkg"') 土 S.D. (N=3) 
* indicates significant difference using student's t-tests assuming equal variances and 
considering both sides of the distribution (2-tailed) in the number of bacteria between 
0 and 24 hours of fermentation (/?<0.05) 
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3.7 Determination of flow rate in three-stage continuous fermentation system 
It was given that the exponential phase of the fecal bacteria might be represented by 
the following equation as demonstrated in the exponential law: 
XrXoeP 
in which is the biomass concentration after t hours; Xo is the original biomass 
concentration; e is the base of the natural logarithm, \i is the specific growth rate 
t is the time interval (h). 
The exponential phase of the fecal bacteria took place in the first 8 hours of the 
inoculation, yielding 3.3 x from 1.42 x microscopic count per ml of fecal 
inoculum (figure 3.15). 
Figure 3.15 The total bacterial growth curve in the batch fermentation system fed 
with enriched fermentation medium 
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The specific growth rate (|i) of the bacterial cells was thus calculated as 0.105 h'\ 
Under the continuous fermentation system, the specific growth rate of the bacteria is 
controlled by the dilution rate. The dilution rate of the continuous fermentation 
system should only be operated below the maximum growth rate of the bacteria 
otherwise cells will be washed out of the vessels at a rate greater than their 
production rate and resulted in a biomass reduction (Stanbury et aL, 1999). 
If the dilution rate of the three-stage continuous fermentation system (300 ml) was 
set at 0.105 h'', which is equivalent to the specific growth rate of the fecal bacteria, 
this results in the flow rate of the system (300ml x 0.105 h"^ ) 31.5 m\h'\ In order to 
prevent biomass reduction in the continuous fermentation system, the flow rate of the 
system should not be faster than 31.5 mlh"\ 
The intestinal transit time in the British community ranges from 20 to 120 hours, 
with the average values of 60 to 70 hours (Cummings et al., 1993). Since very 
limited information about the intestinal transit time in the Chinese community has 
been revealed from previous studies, we proposed that the intestinal transit in 
Chinese community is shorter than that in the British community due to the 
variations in the dietary habits. Therefore, the three-stage continuous system in this 
study was operated at a retention time of 33 hours, with the flow rate of 9.09 mlh"\ 
so as to simulate the bacterial fermentation that occur in the healthy Chinese adult 
large intestine. Since the flow rate of the continuous fermentation system was 
operated below the maximum growth rate of the bacteria, cell growth in the 
fermentation system could be expected. 
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Table 3.2 The operating parameters in the whole system and in different vessels of 
the three-stage in vitro continuous fermentation set-up 
Volume (ml) Dilution rate Retention time (h) 
Whole system 300 0.03 33 
Vessel 1 90 0.10 10 
Vessel 2 100 0.09 11 
Vessel 3 110 0.08 12 
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3.8 Colonic bacterial profile in three-stage continuous fermentation system 
The aim of using the three-stage continuous fermentation system was to study the 
nutritional as well as the environmental conditions in the proximal, transverse and 
distal region of the human colon. Specifically, the fermentation properties of 
fructo-oligosaccharides (positive control) and the most potent prebiotic sugar alcohol 
(lactitol) evaluated by the 24-hour in vitro static culture fermentation study earlier 
(3.6) were further investigate in this 3-stage continuous fermentation system simulate 
the different regions in the human colon. 
3.8.1 Total colonic bacteria 
After 48 hours three-stage in vitro continuous fermentation, FOS (xl2.3) and lactitol 
(xlO.4) stimulated great folds of percentage increases in total bacterial count when 
compared to the reagent blank in vessel 1 (figure 3.16). Most human colonic 
microflora utilize non-digestible carbohydrates as the main energy source and the 
anaerobic degradation of carbohydrates in the colon is a complex processes that 
involves various groups of bacteria with different enzymatic and metabolic pathways 
to form complex metabolic interactions (Roberfroid, 2005). Fermentation culture 
medium fortified with carbohydrates sources (fructo-oligosaccharides or lactitol) can 
thus be hydrolysed by different colonic bacterial secreting enzymes for subsequent 
fermentation, enhance certain bacterial growth and increase in total bacterial count. 
However, the great stimulation of bacterial growth only occurred in vessel 1 since 
carbohydrates fermentation predominated in proximal colon (Macfarlane et al., 
1998). The low pH, due to large quantities of SCFAs production in vessel 1, boost up 
the saccharolytic bacterial growth, however, the stimulation eases towards the distal 
colon (Macfarlane et al,、1992). Besides, the persistency of fructo-oligosaccharides 
(DP=3-10) and lactitol (disaccharides) to pass along the whole colon is limited due to 
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their short chain length. In general, FOS disappeared completely in the proximal 
colon (within 4-5 hours) during human fecal bacterial fermentation (Roberfroid et al, 
1998). Although significant total bacteria increase was still observed in vessel 2 fed 
with 1% FOS/lactitol in fermentation culture medium, the degree of magnitude of 
increase in vessel 2 when compared to the respective blank was much less than that 
obtained in vessel 1 due to limited food provided. Vessel 3, simulating the distal 
colon, was deprived of dietary nutrients supply and thus resulted in insignificant 
percentage increase when fed only with fermentation culture medium or FOS/ lactitol 
fortified fermentation culture medium. 
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Figure 3.16 Percentage of total colonic bacteria increase after 48 hours of three-stage 
continuous fermentation in vessel 1, 2 and 3 fed with different substrates with 
enriched cultivation medium (table 2.1) at 37°C anaerobic condition 
(X: fold of percentage increment with FOS or lactitol when compared with the 
reagent blank at the corresponding vessel) 
Different letters indicate significant difference between the fermentation substrates in 
the same vessel (p<0.05, one-way ANOVA, Tukey's multiple comparison test) 
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3.8.2 Bacteroides 
After 48 hours of three-stage in vitro continuous fermentation, FOS and lactitol 
neither stimulated nor inhibited the Bacteroides population when compared to the 
reagent blank in vessels 1-3 (figure 3.17). It is suggested that Bacteroides do not 
have the ability to secrete P-fructosidase and thus they are less adaptable in medium 
rich in fructo-oligosaccharides (Gibson and Wang, 1994a). Although Bacteroides can 
secrete P-galactosidase and are able to use lactitol as the metabolic substrate, the 
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Figure 3.17 Percentage of Bacteroides increase after 48 hours of three-stage 
continuous fermentation in vessel 1, 2 and 3 fed with different substrates 
(X: absolute fold of percentage increment with FOS or lactitol when compared with 
the reagent blank at the corresponding vessel) 
Different letters indicate significant difference between the fermentation substrates in 
the same vessel (^<0.05, one-way ANOVA, Tukey's multiple comparison test) 
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3.8.3 Bifidobacteria 
After 48 hours of three-stage in vitro continuous fermentation, FOS and lactitol had 
large increase in bifidobacteria! count (31.9 and 39.5 folds, respectively) when 
compared to the reagent blank in vessel 1 (figure 3.18). The significant selective 
stimulation of bifidobacteria! population after 48 hours of continuous fermentation in 
vessel 1 by FOS, confirming the bifidogenic effect of FOS as demonstrated in other 
studies, is caused by several factors (Gibson and Wang, 1994a/b). First, the high 
specificity of FOS as a substrate for Bifidobacteria is due to the activity of specific 
cell-associated P-fructosidase (also known as inulinases), which hydrolyse fructose 
monomers from the non-reducing end of the FOS (Biedrzycka and Bielecka, 2004). 
Second, majority of the Bifidobacterhmi species ferments FOS and glucose equally 
well but the rest of the colonic bacterial genera ferment glucose more efficient than 
FOS (Van Laere et al., 1997). Third, the acidic environment in vessel 1 not only 
inhibits the less acid-tolerated species such as Clostridia but also provides a suitable 
environment for Bifidobacteria proliferation (Rasic, 1983). Similarly, lactitol 
stimulates a significant growth in bifidobacteria! population due to their ability to 
hydrolyse and utilize lactitol with a comparable efficiency as glucose (Lebek and 
Luginbuhl, 1989). 
However, the large percentage increase by FOS and lactitol cannot be continued till 
the distal colon. The main reason is the short-chain length of fructo-oligosaccharides 
and lactitol, which are easily fermented by the colonic bacteria in the proximal colon 
and therefore cannot maintain the prebiotic persistency until the distal colon 
(Roberfroid, 2005). Moreover, the neutral pH environment of vessel 3 is dominated 
by the proteolytic bacteria, therefore further competitions for space and nutrients 
would affect the proliferation rate of Bifidobacteria (Roberfroid, 2005). Although 
linear FOS had more bifidogenic effect than inulin, high DP inulin has the capacity to 
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progress along the transverse colon and reaches the distal colon before being 
completely fermented (Gibson and Wang, 1994d). It is suggested that mixtures of 
FOS with inulin or lactitol with lactitol-oligosaccharides may be an alternative 
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Figure 3.18 Percentage of Bifidobacteria increase after 48 hours of three-stage 
continuous fermentation in vessel 1, 2 and 3 fed with different substrates 
( x : fold of percentage increment with FOS or lactitol when compared with the 
reagent blank at the corresponding vessel) 
Different letters indicate significant difference between the fermentation substrates in 
the same vessel (^<0.05, one-way ANOVA, Tukey's multiple comparison test) 
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3.8.4 Clostridia 
After 48 hours of three-stage in vitro continuous fermentation, FOS and lactitol 
showed a large percentage reduction in clostridial population (10.5 and 10.6 times, 
respectively) when compared to the reagent blank in vessel 1 (figure 3.19). This 
confirmed the results demonstrated by Sghir et al (1998) about the prebiotic effect of 
FOS, in parallel with significant increase in bifidobacteria! and reduction in 
clostridial populations. The significant clostridial reduction in vessel 1 was brought 
by various factors. First of all, Clostridia are predominant in the distal colon, where 
proteolytic activity commonly occurred, the acidification by FOS and lactitol 
fermentation made the proximal colonic environment not suitable for clostridial 
growth (Roberfroid, 2005). Besides, the utilization of FOS and lactitol in Clostridium 
is poor when compared to glucose, in which more than one-third of the Clostridia are 
not able to utilize lactitol as the metabolic substrate (Roberfroid, 2005; Lebek and 
Luginbiihl, 1989). Moreover, the growth of proteolytic bacteria such as Clostridia is 
inhibited by lactitol due to the inhibition of the adhesion of these bacteria to the 
intestinal epithelial cell (Lebek and Luginbiihl, 1989). The stimulation of 
Bifidobacteria by FOS and lactitol also inhibit the clostridial proliferation by 
intensive nutrients competition and antimicrobial agents production (Gibson and 
Wang, 1994c). 
However, the inhibitory effect of FOS and lactitol becomes lesser in the distal colon. 
Since the major site for FOS and lactitol hydrolysis is the proximal colon, the distal 
colon dominated by the proteolytic microorganisms and with neutral pH, which is 
better tolerated by the Clostridia, would not be greatly affected by FOS and lactitol 
intake (Roberfroid, 2005). 
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Figure 3.19 Percentage of Clostridia increase after 48 hours of three-stage 
continuous fermentation in vessel 1, 2 and 3 fed with different substrates 
( x : absolute fold of percentage increment with FOS or lactitol when compared with 
the reagent blank at the corresponding vessel) 
Different letters indicate significant difference between the fermentation substrates in 
the same vessel (^<0.05, one-way ANOVA, Tukey's multiple comparison test) 
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3.8.5 Lactobacilli 
After 48 hours of three-stage in vitro continuous fermentation, FOS and lactitol 
strongly stimulated the growth of Lactobacilli (23.4 and 13.4 folds of increase, 
respectively) when compared to the reagent blank in vessel 1. However, the folds of 
percentage increase were less than that in bifidobacteria! count, which induced x31.9 
and x39.5 folds of percentage increase by FOS and lactitol, respectively (figure 3.18 
and 3.20). Although Lactobacilli is the most-acid tolerated genus among the lactic 
acid bacteria, its low concentration (-0.01%) in the total bacterial population makes 
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Figure 3.20 Percentage of Lactobacilli increase after 48 hours of three-stage 
continuous fermentation in vessel 1, 2 and 3 fed with different substrates 
(X: absolute fold of percentage increment with FOS or lactitol when compared with 
the reagent blank at the corresponding vessel) 
Different letters indicate significant difference between the fermentation substrates in 
the same vessel (^<0.05, one-way ANOVA, Tukey's multiple comparison test) 
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3.9 SCFAs in three-stage continuous fermentation system 
3.9.1 Total SCFA concentration 
The total short-chain fatty acids concentration increased significantly (p<0.05) after 
24 and 48 hours in vitro continuous fermentation in all the three vessels, simulating 
the proximal, transverse and distal region of the human colon, when compared with 
the initial inoculum fed with fermentation culture medium (reagent blank) and 1% 
(w/v) FOS/ lactitol in fermentation culture medium (tables 3.3-3.5). The increase in 
the total SCFAs concentration indicated that there was a significant boost in the 
growth and proliferation of the bacterial populations during the continuous 
fermentation. Both FOS and lactitol can neither be digested nor absorbed in the 
human upper gastrointestinal tract due to the inability of the human secreting 
enzymes to breakdown specific (3 -glycosidic bonds between monomers in FOS and 
lactitol molecules for digestion and absorption (Gibson et al, 2004; Olinger and 
Pepper, 2001). Therefore, the intake of FOS or lactitol would eventually reach the 
human colon for bacterial fermentation and thus enhances the SCFAs production 
markedly in different parts of the human colon. Since more than 95% of the SCFAs 
production in colon are absorbed and utilized by the host, the increase of SCFAs 
concentration by FOS and lactitol can thus recover some of the energy escaped from 
the absorption and digestion in the upper gastrointestinal tract (Cummings, 1995). As 
well, the large SCFA production by FOS and lactitol reduced the colonic pH, which 
favours the growth of the acid-tolerant genera such as Bifidobacteria and 
Lactobacilli and suppresses the health-deteriorating genera such as Clostridia in the 
healthy human colonic environment (Walker et al., 2005; Gibson and Wang, 1994b). 
Reduction of the colonic pH due to increased SCFA production can also facilitate 
minerals absorption by the enhancement of passive and active minerals transport 
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across the human intestinal epithelium (Ahrens and Schrezenmeir, 2002). An added 
advantage of acid production during bacterial fermentation is the protonation of the 
potentially toxic substances such as ammonia and amines to ammonium, which is 
non-diffijsable and thus reduces the ammonia level in blood (Hansen, 1985). 
After 48 hours of continuous fermentation, fecal bacteria fed solely with 
fermentation culture medium yielded 93%, 280% and 246% of increase in the total 
SCFA concentration in V I , V2 and V3, respectively. While fecal bacteria fed with 
1% (w/v) FOS/ lactitol in fermentation culture medium showed 994%/ 1026%, 
1071%/ 1409% and 1182%/ 1225% of increase in the total SCFAs concentration in 
VI，V2 and V3, respectively (figure 3.21). Vessel 1 in the three-stage continuous 
fermentation system, imitating the human proximal colonic environment, fed either 
with FOS or lactitol fortified fermentation culture medium had the largest percentage 
increment (figure 3.21). Because of the adequate substrates availability, majority of 
the SCFA production takes place in the proximal region of the human colon 
(Cummings et al., 1987). However, such large increments cannot be sustained in 
vessels 2 and 3 fed either with FOS or lactitol. This was because FOS and lactitol 
have a low degree of polymerization, with 3-10 in FOS and 2 in lactitol. Such small 
molecules are readily digested and absorbed by the colonic bacteria situated at the 
proximal colon (Biedrzycka and Bielecka, 2004). Only those that can escape the 
fermentation in VI and reached V2 and V3 for subsequent bacterial fermentation can 
result in a less percentage increment in the transverse and distal region of the human 
colon. 
83 
U, 1600 「 
� x5.0 
<v 产 1400 ~ 
S § doX5.0 
^ x4.8 
g I 1200 — = r T -
- � xll.O x3.8 F 
.1 在 1000 -^dxUj—I R — 
I W • Reagent blank 
8 § 800 ——疆 : 一 D F O S 
8 "I • U • • Lactitol 
^ 8 _ • • • -
I I 400 Q b ————Jb — 
I “ 200 - J — r l — 
^ 0 , \m I \.m I 
VI V2 V3 
Figure 3.21 Percentage of total SCFAs concentration increase after 48 hours of 
three-stage continuous fermentation in vessel 1, 2 and 3 fed with different substrates 
( x : fold of percentage increment with FOS or lactitol when compared with the 
reagent blank at the corresponding vessel) 
Different letters indicate significant difference between fermentation substrates in the 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.9.2 Short-chain fatty acid molar ratio 
The SCFA molar ratio of acetate to propionate to butyrate in the initial inoculum 
incubated at all the vessels, fed with fermentation culture medium and 1% (w/v) 
FOS/ lactitol in fermentation culture medium, was about 60; 20: 20, which is similar 
to that revealed by Cummings et al. (1987) (tables 3.3-3.5). Acetate was the major 
SCFA produced by the colonic bacteria followed by propionate and butyrate in the 
fecal slurry at 0 hour. The SCFAs molar ratio remained more or less the same during 
the continuous fermentation after 24 and 48 hours in all the vessels when fed only 
with the fermentation culture medium. However, the proportion of SCFAs shifted 
when the fermentation culture medium was fortified with FOS or lactitol in the 
continuous fermentation system (tables 3.3-3.5). In general, the SCFA concentration 
profile of FOS and lactitol was modified to yield largest amount of acetate followed 
by butyrate and propionate after 24 and 48 hours of continuous fermentation. Since 
FOS and lactitol have the ability to selectively stimulate and/ or suppress certain 
bacterial genera growth as demonstrated in section 3.8, which would in turn alter the 
colonic bacterial profile and affect the molar ratio of the resulting metabolites 
(SCFAs). The increase in the relative proportion of butyrate confirmed the 
butyrogenic effect of FOS as demonstrated by Djouzi and Andieux (1997)，which 
induced an increase, from 8% of butyrate in control rats to 34% of butyrate in FOS 
feeding rats in total SCFAs concentration. 
The increase of butyrate concentration by FOS and lactitol may be due to the 
significant increase of the non-clostridial lactate utilizing butyrate producers such as 
Eubacterium Hallii and lactate producers such as Bifidobacteria or significant 
inhibition of the propionate producers (Hold et al, 2003). In fact, the increase in 
butyrate concentration has several beneficial outcomes in the human colon such as 
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anti-cancerous effect (Roediger, 1980 and 1995; Pradad, 1980). It has also been 
proposed that the potential of selectively increasing the non-clostridial butyrate 
producers' population in the colon is one of the new targets for the emerging 
prebiotics when compared to the traditional prebiotics, aimed only at the 
Bifidobacterium spp. and Lactobacillus spp. (Rastall et al, 2005). However, the 
largest increase in butyrate percentage feeding either with FOS or lactitol occurred in 
vessel 1 while the degree of increase reduced in vessel 2 and 3, which can be 
explained that the majority of carbohydrates fermentation is predominated in the 
proximal colon but in less extent in the transverse and distal colon (Macfarlane et al., 
1998). Therefore the huge increase in butyrate percentage might not be maintained 
throughout the human colon by the intake of FOS or lactitol. 
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3.9.3 Acetate 
The acetate concentration in vessel 1, 2 and 3 fed with fermentation culture medium 
and 1% (w/v) FOS/ lactitol in fermentation culture medium were presented in tables 
3.3-3.5, respectively. Since most of the predominant colonic bacteria (Bifidobacteria, 
Bacteroides, eubacteria, Clostridia, Fusobacteria, etc.) are the acetate producers, 
increase in the total bacterial populations can enhance acetate production in the colon 
(Cummings et al., 1987). During continuous fermentation with different substrates, 
the acetate concentration was significantly increased in all the vessels (p<0.05), 
however, the molar ratio of acetate in the overall SCFAs profile remained constant, 
which accounted for about 60% of the total SCFAs concentration (tables 3.3-3.5). It 
is believed that acetate is produced by a wide range of colonic bacteria; certain 
increase or decrease in specific bacterial population might not affect the overall 
molar ratio of acetate. 
After 48 hours of continuous fermentation, fecal bacteria fed solely with 
fermentation culture medium yielded 90%, 327% and 250% of increase in acetate 
concentration in VI, V2 and V3, respectively. While fecal bacteria fed with 1% (w/v) 
FOS/ lactitol in fermentation culture medium demonstrated 981%/ 933%, 1105%/ 
1421% and 1170%/ 1230% of increase in acetate concentration in VI , V2 and V3, 
respectively (figure 3.22). Fructose is one of the best substrates for lactate and 
acetate production by Bifidobacteria (Sangeetha et al., 2005). Fructose utilization 
following FOS hydrolysis by the significant increase of bifidobacteria! population 
can produce substantial amount of acetate and thus lead to more than 10 times of the 
percentage increment in vessel 1 during the continuous fermentation fed with 1% 
FOS when compared to the reagent blank (figure 3.22). As well, lactitol seemed to be 
another good substrate for the general bacterial population, which caused a 10.3 
90 
times of percentage increment in the acetate concentration when compared to the 
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Figure 3.22 Percentage of acetate concentration increase after 48 hours of three-stage 
continuous fermentation in vessel 1, 2 and 3 fed with different substrates 
( x : fold of percentage increment with FOS or lactitol when compared with the 
reagent blank at the corresponding vessel) 
Different letters indicate significant difference between fermentation substrates in the 
same vessel (/?<0.05, one-way ANOVA, Tukey's multiple comparison test) 
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3.9.4 Propionate 
The propionate concentration in vessel 1, 2 and 3 fed simply with fermentation 
culture medium and 1% (w/v) FOS/ lactitol in fermentation culture medium were 
presented in tables 3.3-3.5. Significant increase in the propionate concentration after 
48 hours of continuous fermentation was observed in vessel 1 fed only with 
fermentation culture medium (p<0.05) (table 3.3). However, the propionate 
concentration in vessel 1 after 48 hours of continuous fermentation, was reduced 
significantly (p<0.05) when fed with FOS, but remained constant (p>0.05) when fed 
with lactitol (table 3.3). It is suggested that vessel 1 is the predominant site for FOS 
and lactitol fermentations, which selectively stimulate certain non-propionate 
producing species such as Bifidobacteria and inhibit certain propionate producing 
species such as Bacteroides and Propionibacterium causing a reduction in the 
propionate concentration. 
After 48 hours of continuous fermentation, fecal bacteria fed exclusively with 
fermentation culture medium yielded 60%, 152% and 176% of increase in propionate 
concentration in VI , V2 and V3, respectively. While fecal bacteria fed with 1% (w/v) 
FOS/ lactitol in fermentation culture medium showed -31%/ 9%, 145%/ 579% and 
433%/ 874% of increase in propionate concentration in VI, V2 and V3, respectively 
(figure 3.23). Both FOS and lactitol showed the strongest inhibition in propionate 
concentration in vessel 1 and the inhibitory effect reduced when they passed along 
the colon because of substrates exhaustion. 
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Figure 3.23 Percentage of propionate concentration increase after 48 hours of 
three-stage continuous fermentation in vessel 1, 2 and 3 fed with different substrates 
( x : absolute fold of percentage increment with FOS or lactitol when compared with 
the reagent blank at the corresponding vessel) 
Different letters indicate significant difference between fermentation substrates in the 
same vessel (p<0.05, one-way ANOVA, Tukey's multiple comparison test) 
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3.9.5 Butyrate 
The butyrate concentration in vessel 1, 2 and 3 fed with fermentation culture medium 
and 1% (w/v) FOS/ lactitol in fermentation culture medium were presented in tables 
3.3-3.5. In general, butyrate is the least produced SCFA during colonic fermentation 
and in general Clostridhwi, Eubacterium and Fiisobacteriiim are the most frequent 
butyrate producers (Cummings et al., 1987). However, during colonic fermentation, 
FOS and lactitol have the selective ability to stimulate the proliferation of the 
lactate-producing bacteria such as Bifidobacteria and Lactobacilli in the colon 
(Roberfroid et al., 1998; Ballongue et al, 1997). In fact, lactate does not accumulate 
in the complex colonic ecosystem, it can be transformed through bacterial metabolic 
pathways to propionate (via succinate) and ultimately to butyrate (Roberfroid, 2005). 
After 48 hours of continuous fermentation, fecal bacteria fed only with fermentation 
culture medium yielded 155%, 326% and 355% of increase in butyrate concentration 
in VI , V2 and V3, respectively. While fecal bacteria fed with 1% (w/v) FOS/ lactitol 
in fermentation culture medium showed 3109%/ 3051%, 2833%/ 2608% and 2780%/ 
1701% of increase in butyrate concentration in VI, V2 and V3, respectively (figure 
3.24). Both FOS and lactitol are capable of boosting about 20 times more than the 
reagent blank in the percentage of butyrate concentration after 48 hours of 
continuous fermentation, which confirmed the butyrogenic effect of FOS by Le Blay 
et al. (1999). Butyrate has a concentration-dependent decrease in the rate of 
transformed cancer cell growth and has the ability to reverse cells from a neoplastic 
to a non-neoplastic phenotype (Gibson et al, 1992). Increase in butyrate 






3000 • ^ 
2 5 0 。 • —Bn—• 
I 2000 • 1 I _ _ 國 Reagent blai^ 
•运 • • • X4.8 
• • • • Lactitol 
！^ 1000 • H M b 一 
i 5 。 。 一 - • ^ -
^M 
Q I—S-JI^I I——I—_BBBH I—— I 
VI V2 V3 
Figure 3.24 Percentage of butyrate concentration increase after 48 hours of 
three-stage continuous fermentation in vessel 1, 2 and 3 fed with different substrates 
( x : fold of percentage increment with FOS or lactitol when compared with the 
reagent blank at the corresponding vessel) 
Different letters indicate significant difference between fermentation substrates in the 
same vessel (p<0.05, one-way ANOVA, Tukey's multiple comparison test) 
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Chapter 4. Conclusions and Future Work 
Table 4.1 Summary table for 24 hours batch fermentation system with different sugar 
alcohols and FOS 
F ^ Xylitol SorbitolMannitol Lactitol 
Total bacteria + • • • + 
^ Bacteroides 鲁 • 鲁 鲁 鲁 
I 
Bifidobacteria + - • • + 
•c 
<L) 
^ Clostridia - -
PQ 
^Lactobacilli • - • • • 
Total SCFA + + + + + 
^ 
^ Acetate + • + + + 
^ 
^ Propionate + + + + + 
u 
CO 
Butyrate + + + + + 
+: Significant increase (/?<0.05) in bacterial population or SCFA production was 
observed after 24 hours of batch fermentation; -: Significant decrease (^<0.05) in 
bacterial populations or SCFA production was observed after 24 hours of batch 
fermentation; •: Insignificant increase/ decrease (^>0.05) in bacterial populations or 
SCFA production was observed after 24 hours of batch fermentation 
Lactitol was shown to be the most potential novel prebiotics in terms of its selectivity 
to increase bifidobacteria! and reduce clostridial population in the present 24-hour in 
vitro batch culture fermentation study incubated with human fecal slurry (table 4.1). 
Although sorbitol, mannitol and xylitol could not induce a significant (p<0.05) 
increase in the growth of Bifidobacteria and Lactohacilli, they did reduce 
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significantly (p<0.05) the population of Clostridium and lowered colonic pH. 
Table 4.2 Summary table for the fold of percentage increment in bacterial/ SCFA 
profile with FOS and lactitol after 48 hours continuous fermentation when compared 
with the reagent blank in vessels 1, 2 and 3 
FOS Lactitol 
V\ ^ ^ VI V2 V3 
Total bacteria xl2.3 7x2 xLO xlO.4 xh2 xl.O 
^ Bacteroides ^ x L O ^ xl.O 
0 
^ 
^ Bifidobacteria x31.9 x3.6 x2.5 x39.5 x3.9 x2.1 
.c 
^ 
1 ^Clostridia x(10.5) x(0.6) ^ x ( 1 0 . 6 ) x ( 0 . 4 ) xO.8 
Lactobacilli x23.4 xl.3 xl.O xl3.4 xl.O xl.O 
Total SCFA xlO.7 xll.O x5.0 
j j 
S Acetate xlO.9 x3.4 x4.7 xlO.3 x4.3 x4.9 
o^ 
；2 Propionate x(0.5) xO.95 x2.5 xO.2 x3.8 x5.0 
u 
00 
Butyrate x20.0 xl9.7 x4.8 
Values in bracket indicated fold of percentage decrement in bacterial/ SCFA 
concentrations after 48 hours continuous fermentation 
The most potent sugar alcohol, lactitol, consistently exhibited its prebiotic effects in 
the in vitro three-stage continuous fermentation study by selectively increasing the 
bifidobacteria! and suppressing the clostridial counts significantly (p<0.05) 
throughout the three vessels, which simulate different parts of the human colon (table 
4.2). Lactitol also demonstrated its ability to modify the short-chain fatty acid profile 
97 
by increasing the butyrate proportion in the total SCFAs, which adds further 
advantage to maintain a human healthy gut. 
The significantly huge increase both in the beneficial bacterial populations and the 
short-chain fatty acid concentrations in vessel 1 (proximal colon) could not be 
observed in vessel 2 (transverse colon) and vessel 3 (distal colon) in the continuous 
fermentation system because of the short chain length of lactitol and FOS. However, 
increase in chain length or branching may affect the fermentation properties of the 
fermentation compounds (Rycroft et al., 2001). For example, the fermentation rate of 
oligomers with DP less than 10 is twice as fast as that of the molecules with DP more 
than 10 (Perrin et al., 2002). To increase the persistency of the beneficial effects of 
lactitol, a combination mixture of lactitol and lactitol-oligosaccharides (3<DP<20) 
can be used so as to bring out a similar synergetic effect by the combination of inulin 
and FOS on prebiotic potential in terms of persistency (Rastall et al., 2005). 
All in all, sorbitol, mannitol and xylitol seem to have potential health promoting 
effect to the human gut, in addition to their use to replace sucrose in our diet, while 
lactitol appears to be the most effective sugar alcohol prebiotic candidate. Due to the 
limitations of the in vitro fermentation systems, which cannot truly simulate the 
physiology of the human colon such as epithelial bacterial colonization and 
short-chain fatty acid absorption, further evaluation by in vivo and human clinical 
studies might give deeper insight to the use of lactitol as a novel prebiotics. 
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